{
  "ticker": "EW",
  "last_updated": "2025-04-19T10:04:54.704574",
  "retention_years": 3,
  "count": 1041,
  "transactions": [
    {
      "id": 369864,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2025-04-14",
      "transaction_shares": "9500.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "56706.3707"
    },
    {
      "id": 369831,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2025-04-08",
      "transaction_shares": "300.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "23163.1066"
    },
    {
      "id": 323122,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2025-03-26",
      "transaction_shares": "11250.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "41637.0000"
    },
    {
      "id": 369799,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2025-03-26",
      "transaction_shares": "11250.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "41637.0000"
    },
    {
      "id": 323191,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2025-03-13",
      "transaction_shares": "9500.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "56435.7184"
    },
    {
      "id": 369870,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2025-03-13",
      "transaction_shares": "9500.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "56435.7184"
    },
    {
      "id": 323179,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2025-03-10",
      "transaction_shares": "400.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "22988.0651"
    },
    {
      "id": 323188,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2025-03-10",
      "transaction_shares": "7463.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "66545.9006"
    },
    {
      "id": 369857,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2025-03-10",
      "transaction_shares": "400.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "22988.0651"
    },
    {
      "id": 369867,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2025-03-10",
      "transaction_shares": "7463.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "66545.9006"
    },
    {
      "id": 279965,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2025-02-28",
      "transaction_shares": "11250.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "41637.0000"
    },
    {
      "id": 323126,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2025-02-28",
      "transaction_shares": "11250.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "41637.0000"
    },
    {
      "id": 369803,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2025-02-28",
      "transaction_shares": "11250.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "41637.0000"
    },
    {
      "id": 280029,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Dahl Andrew M.",
      "reporting_owner_cik": "0002022347",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2025-02-22",
      "transaction_shares": "176.0000",
      "transaction_price": "73.3000",
      "transaction_type": "F",
      "shares_after_transaction": "4684.1255"
    },
    {
      "id": 323193,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Dahl Andrew M.",
      "reporting_owner_cik": "0002022347",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2025-02-22",
      "transaction_shares": "176.0000",
      "transaction_price": "73.3000",
      "transaction_type": "F",
      "shares_after_transaction": "4684.1255"
    },
    {
      "id": 369872,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Dahl Andrew M.",
      "reporting_owner_cik": "0002022347",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2025-02-22",
      "transaction_shares": "176.0000",
      "transaction_price": "73.3000",
      "transaction_type": "F",
      "shares_after_transaction": "4684.1255"
    },
    {
      "id": 279973,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2025-02-16",
      "transaction_shares": "174.0000",
      "transaction_price": "76.1900",
      "transaction_type": "F",
      "shares_after_transaction": "30387.0000"
    },
    {
      "id": 279982,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2025-02-16",
      "transaction_shares": "333.0000",
      "transaction_price": "76.1900",
      "transaction_type": "F",
      "shares_after_transaction": "198192.7390"
    },
    {
      "id": 280005,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2025-02-16",
      "transaction_shares": "214.0000",
      "transaction_price": "76.1900",
      "transaction_type": "F",
      "shares_after_transaction": "22975.0651"
    },
    {
      "id": 323134,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2025-02-16",
      "transaction_shares": "174.0000",
      "transaction_price": "76.1900",
      "transaction_type": "F",
      "shares_after_transaction": "30387.0000"
    },
    {
      "id": 323143,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2025-02-16",
      "transaction_shares": "333.0000",
      "transaction_price": "76.1900",
      "transaction_type": "F",
      "shares_after_transaction": "198192.7390"
    },
    {
      "id": 323166,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2025-02-16",
      "transaction_shares": "214.0000",
      "transaction_price": "76.1900",
      "transaction_type": "F",
      "shares_after_transaction": "22975.0651"
    },
    {
      "id": 369811,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2025-02-16",
      "transaction_shares": "174.0000",
      "transaction_price": "76.1900",
      "transaction_type": "F",
      "shares_after_transaction": "30387.0000"
    },
    {
      "id": 369820,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2025-02-16",
      "transaction_shares": "333.0000",
      "transaction_price": "76.1900",
      "transaction_type": "F",
      "shares_after_transaction": "198192.7390"
    },
    {
      "id": 369844,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2025-02-16",
      "transaction_shares": "214.0000",
      "transaction_price": "76.1900",
      "transaction_type": "F",
      "shares_after_transaction": "22975.0651"
    },
    {
      "id": 279989,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LORANGER STEVEN R",
      "reporting_owner_cik": "0001226924",
      "reporting_owner_position": null,
      "transaction_date": "2025-02-14",
      "transaction_shares": "5739.0000",
      "transaction_price": "45.3167",
      "transaction_type": "M",
      "shares_after_transaction": "66111.0000"
    },
    {
      "id": 323150,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LORANGER STEVEN R",
      "reporting_owner_cik": "0001226924",
      "reporting_owner_position": null,
      "transaction_date": "2025-02-14",
      "transaction_shares": "5739.0000",
      "transaction_price": "45.3167",
      "transaction_type": "M",
      "shares_after_transaction": "66111.0000"
    },
    {
      "id": 369827,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LORANGER STEVEN R",
      "reporting_owner_cik": "0001226924",
      "reporting_owner_position": null,
      "transaction_date": "2025-02-14",
      "transaction_shares": "5739.0000",
      "transaction_price": "45.3167",
      "transaction_type": "M",
      "shares_after_transaction": "66111.0000"
    },
    {
      "id": 279963,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2025-02-13",
      "transaction_shares": "6500.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "53435.7184"
    },
    {
      "id": 279993,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2025-02-13",
      "transaction_shares": "5739.0000",
      "transaction_price": "45.3167",
      "transaction_type": "M",
      "shares_after_transaction": "35774.0000"
    },
    {
      "id": 280003,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2025-02-13",
      "transaction_shares": "11250.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "41811.0000"
    },
    {
      "id": 280016,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2025-02-13",
      "transaction_shares": "500.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "23689.0651"
    },
    {
      "id": 323124,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2025-02-13",
      "transaction_shares": "6500.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "53435.7184"
    },
    {
      "id": 323154,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2025-02-13",
      "transaction_shares": "5739.0000",
      "transaction_price": "45.3167",
      "transaction_type": "M",
      "shares_after_transaction": "35774.0000"
    },
    {
      "id": 323164,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2025-02-13",
      "transaction_shares": "11250.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "41811.0000"
    },
    {
      "id": 323177,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2025-02-13",
      "transaction_shares": "500.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "23689.0651"
    },
    {
      "id": 369801,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2025-02-13",
      "transaction_shares": "6500.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "53435.7184"
    },
    {
      "id": 369832,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2025-02-13",
      "transaction_shares": "5739.0000",
      "transaction_price": "45.3167",
      "transaction_type": "M",
      "shares_after_transaction": "35774.0000"
    },
    {
      "id": 369842,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2025-02-13",
      "transaction_shares": "11250.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "41811.0000"
    },
    {
      "id": 369855,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2025-02-13",
      "transaction_shares": "500.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "23689.0651"
    },
    {
      "id": 242225,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2025-01-16",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 242256,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2025-01-16",
      "transaction_shares": "500.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "23689.0651"
    },
    {
      "id": 280012,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2025-01-16",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 280045,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2025-01-16",
      "transaction_shares": "500.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "23689.0651"
    },
    {
      "id": 323173,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2025-01-16",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 323209,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2025-01-16",
      "transaction_shares": "500.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "23689.0651"
    },
    {
      "id": 369851,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2025-01-16",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 369888,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2025-01-16",
      "transaction_shares": "500.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "23689.0651"
    },
    {
      "id": 208232,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-12-16",
      "transaction_shares": "2500.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "25689.0651"
    },
    {
      "id": 242238,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-12-16",
      "transaction_shares": "2500.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "25689.0651"
    },
    {
      "id": 280026,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-12-16",
      "transaction_shares": "2500.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "25689.0651"
    },
    {
      "id": 323189,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-12-16",
      "transaction_shares": "2500.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "25689.0651"
    },
    {
      "id": 369868,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-12-16",
      "transaction_shares": "2500.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "25689.0651"
    },
    {
      "id": 208184,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-12-09",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 208244,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-12-09",
      "transaction_shares": "11250.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "41811.0000"
    },
    {
      "id": 242189,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-12-09",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 242250,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-12-09",
      "transaction_shares": "11250.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "41811.0000"
    },
    {
      "id": 279970,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-12-09",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 280039,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-12-09",
      "transaction_shares": "11250.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "41811.0000"
    },
    {
      "id": 323131,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-12-09",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 323203,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-12-09",
      "transaction_shares": "11250.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "41811.0000"
    },
    {
      "id": 369808,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-12-09",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 369882,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-12-09",
      "transaction_shares": "11250.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "41811.0000"
    },
    {
      "id": 208198,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Markowitz Wayne",
      "reporting_owner_cik": "0001991414",
      "reporting_owner_position": "GM & SVP, Surgical",
      "transaction_date": "2024-12-06",
      "transaction_shares": "583.0000",
      "transaction_price": "73.2700",
      "transaction_type": "S",
      "shares_after_transaction": "9493.8468"
    },
    {
      "id": 208221,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-12-06",
      "transaction_shares": "1750.0000",
      "transaction_price": "73.2701",
      "transaction_type": "S",
      "shares_after_transaction": "27583.0000"
    },
    {
      "id": 242203,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Markowitz Wayne",
      "reporting_owner_cik": "0001991414",
      "reporting_owner_position": "GM & SVP, Surgical",
      "transaction_date": "2024-12-06",
      "transaction_shares": "583.0000",
      "transaction_price": "73.2700",
      "transaction_type": "S",
      "shares_after_transaction": "9493.8468"
    },
    {
      "id": 242227,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-12-06",
      "transaction_shares": "1750.0000",
      "transaction_price": "73.2701",
      "transaction_type": "S",
      "shares_after_transaction": "27583.0000"
    },
    {
      "id": 279986,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Markowitz Wayne",
      "reporting_owner_cik": "0001991414",
      "reporting_owner_position": "GM & SVP, Surgical",
      "transaction_date": "2024-12-06",
      "transaction_shares": "583.0000",
      "transaction_price": "73.2700",
      "transaction_type": "S",
      "shares_after_transaction": "9493.8468"
    },
    {
      "id": 280014,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-12-06",
      "transaction_shares": "1750.0000",
      "transaction_price": "73.2701",
      "transaction_type": "S",
      "shares_after_transaction": "27583.0000"
    },
    {
      "id": 323147,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Markowitz Wayne",
      "reporting_owner_cik": "0001991414",
      "reporting_owner_position": "GM & SVP, Surgical",
      "transaction_date": "2024-12-06",
      "transaction_shares": "583.0000",
      "transaction_price": "73.2700",
      "transaction_type": "S",
      "shares_after_transaction": "9493.8468"
    },
    {
      "id": 323175,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-12-06",
      "transaction_shares": "1750.0000",
      "transaction_price": "73.2701",
      "transaction_type": "S",
      "shares_after_transaction": "27583.0000"
    },
    {
      "id": 369824,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Markowitz Wayne",
      "reporting_owner_cik": "0001991414",
      "reporting_owner_position": "GM & SVP, Surgical",
      "transaction_date": "2024-12-06",
      "transaction_shares": "583.0000",
      "transaction_price": "73.2700",
      "transaction_type": "S",
      "shares_after_transaction": "9493.8468"
    },
    {
      "id": 369853,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-12-06",
      "transaction_shares": "1750.0000",
      "transaction_price": "73.2701",
      "transaction_type": "S",
      "shares_after_transaction": "27583.0000"
    },
    {
      "id": 176684,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-11-13",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 208169,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-11-13",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 242174,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-11-13",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 279953,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-11-13",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 323113,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-11-13",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 369790,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-11-13",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 176760,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-11-05",
      "transaction_shares": "25000.0000",
      "transaction_price": "65.9145",
      "transaction_type": "S",
      "shares_after_transaction": "198525.7390"
    },
    {
      "id": 208250,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-11-05",
      "transaction_shares": "25000.0000",
      "transaction_price": "65.9145",
      "transaction_type": "S",
      "shares_after_transaction": "198525.7390"
    },
    {
      "id": 242257,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-11-05",
      "transaction_shares": "25000.0000",
      "transaction_price": "65.9145",
      "transaction_type": "S",
      "shares_after_transaction": "198525.7390"
    },
    {
      "id": 280046,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-11-05",
      "transaction_shares": "25000.0000",
      "transaction_price": "65.9145",
      "transaction_type": "S",
      "shares_after_transaction": "198525.7390"
    },
    {
      "id": 323210,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-11-05",
      "transaction_shares": "25000.0000",
      "transaction_price": "65.9145",
      "transaction_type": "S",
      "shares_after_transaction": "198525.7390"
    },
    {
      "id": 369889,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-11-05",
      "transaction_shares": "25000.0000",
      "transaction_price": "65.9145",
      "transaction_type": "S",
      "shares_after_transaction": "198525.7390"
    },
    {
      "id": 147706,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-10-15",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 176707,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-10-15",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 208193,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-10-15",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 242198,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-10-15",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 279980,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-10-15",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 323141,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-10-15",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 369818,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-10-15",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 120797,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Markowitz Wayne",
      "reporting_owner_cik": "0001991414",
      "reporting_owner_position": "GM & SVP, Surgical",
      "transaction_date": "2024-09-14",
      "transaction_shares": "648.0000",
      "transaction_price": "68.5200",
      "transaction_type": "F",
      "shares_after_transaction": "10033.0463"
    },
    {
      "id": 147708,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Markowitz Wayne",
      "reporting_owner_cik": "0001991414",
      "reporting_owner_position": "GM & SVP, Surgical",
      "transaction_date": "2024-09-14",
      "transaction_shares": "648.0000",
      "transaction_price": "68.5200",
      "transaction_type": "F",
      "shares_after_transaction": "10033.0463"
    },
    {
      "id": 176709,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Markowitz Wayne",
      "reporting_owner_cik": "0001991414",
      "reporting_owner_position": "GM & SVP, Surgical",
      "transaction_date": "2024-09-14",
      "transaction_shares": "648.0000",
      "transaction_price": "68.5200",
      "transaction_type": "F",
      "shares_after_transaction": "10033.0463"
    },
    {
      "id": 208195,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Markowitz Wayne",
      "reporting_owner_cik": "0001991414",
      "reporting_owner_position": "GM & SVP, Surgical",
      "transaction_date": "2024-09-14",
      "transaction_shares": "648.0000",
      "transaction_price": "68.5200",
      "transaction_type": "F",
      "shares_after_transaction": "10033.0463"
    },
    {
      "id": 242200,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Markowitz Wayne",
      "reporting_owner_cik": "0001991414",
      "reporting_owner_position": "GM & SVP, Surgical",
      "transaction_date": "2024-09-14",
      "transaction_shares": "648.0000",
      "transaction_price": "68.5200",
      "transaction_type": "F",
      "shares_after_transaction": "10033.0463"
    },
    {
      "id": 279983,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Markowitz Wayne",
      "reporting_owner_cik": "0001991414",
      "reporting_owner_position": "GM & SVP, Surgical",
      "transaction_date": "2024-09-14",
      "transaction_shares": "648.0000",
      "transaction_price": "68.5200",
      "transaction_type": "F",
      "shares_after_transaction": "10033.0463"
    },
    {
      "id": 323144,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Markowitz Wayne",
      "reporting_owner_cik": "0001991414",
      "reporting_owner_position": "GM & SVP, Surgical",
      "transaction_date": "2024-09-14",
      "transaction_shares": "648.0000",
      "transaction_price": "68.5200",
      "transaction_type": "F",
      "shares_after_transaction": "10033.0463"
    },
    {
      "id": 369821,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Markowitz Wayne",
      "reporting_owner_cik": "0001991414",
      "reporting_owner_position": "GM & SVP, Surgical",
      "transaction_date": "2024-09-14",
      "transaction_shares": "648.0000",
      "transaction_price": "68.5200",
      "transaction_type": "F",
      "shares_after_transaction": "10033.0463"
    },
    {
      "id": 120777,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Dahl Andrew M.",
      "reporting_owner_cik": "0002022347",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-09-13",
      "transaction_shares": "2920.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "4690.7834"
    },
    {
      "id": 147687,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Dahl Andrew M.",
      "reporting_owner_cik": "0002022347",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-09-13",
      "transaction_shares": "2920.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "4690.7834"
    },
    {
      "id": 176688,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Dahl Andrew M.",
      "reporting_owner_cik": "0002022347",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-09-13",
      "transaction_shares": "2920.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "4690.7834"
    },
    {
      "id": 208173,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Dahl Andrew M.",
      "reporting_owner_cik": "0002022347",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-09-13",
      "transaction_shares": "2920.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "4690.7834"
    },
    {
      "id": 242178,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Dahl Andrew M.",
      "reporting_owner_cik": "0002022347",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-09-13",
      "transaction_shares": "2920.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "4690.7834"
    },
    {
      "id": 279957,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Dahl Andrew M.",
      "reporting_owner_cik": "0002022347",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-09-13",
      "transaction_shares": "2920.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "4690.7834"
    },
    {
      "id": 323117,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Dahl Andrew M.",
      "reporting_owner_cik": "0002022347",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-09-13",
      "transaction_shares": "2920.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "4690.7834"
    },
    {
      "id": 369794,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Dahl Andrew M.",
      "reporting_owner_cik": "0002022347",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-09-13",
      "transaction_shares": "2920.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "4690.7834"
    },
    {
      "id": 120789,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-09-11",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 147699,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-09-11",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 176700,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-09-11",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 208186,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-09-11",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 242191,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-09-11",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 279972,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-09-11",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 323133,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-09-11",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 369810,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-09-11",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 120781,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-09-03",
      "transaction_shares": "10910.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "86817.4373"
    },
    {
      "id": 147691,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-09-03",
      "transaction_shares": "10910.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "86817.4373"
    },
    {
      "id": 176692,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-09-03",
      "transaction_shares": "10910.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "86817.4373"
    },
    {
      "id": 208177,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-09-03",
      "transaction_shares": "10910.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "86817.4373"
    },
    {
      "id": 242182,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-09-03",
      "transaction_shares": "10910.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "86817.4373"
    },
    {
      "id": 279961,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-09-03",
      "transaction_shares": "10910.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "86817.4373"
    },
    {
      "id": 323121,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-09-03",
      "transaction_shares": "10910.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "86817.4373"
    },
    {
      "id": 369798,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-09-03",
      "transaction_shares": "10910.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "86817.4373"
    },
    {
      "id": 95887,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-08-20",
      "transaction_shares": "1250.0000",
      "transaction_price": "69.9501",
      "transaction_type": "S",
      "shares_after_transaction": "29333.0000"
    },
    {
      "id": 120799,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-08-20",
      "transaction_shares": "1250.0000",
      "transaction_price": "69.9501",
      "transaction_type": "S",
      "shares_after_transaction": "29333.0000"
    },
    {
      "id": 147710,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-08-20",
      "transaction_shares": "1250.0000",
      "transaction_price": "69.9501",
      "transaction_type": "S",
      "shares_after_transaction": "29333.0000"
    },
    {
      "id": 176711,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-08-20",
      "transaction_shares": "1250.0000",
      "transaction_price": "69.9501",
      "transaction_type": "S",
      "shares_after_transaction": "29333.0000"
    },
    {
      "id": 208197,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-08-20",
      "transaction_shares": "1250.0000",
      "transaction_price": "69.9501",
      "transaction_type": "S",
      "shares_after_transaction": "29333.0000"
    },
    {
      "id": 242202,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-08-20",
      "transaction_shares": "1250.0000",
      "transaction_price": "69.9501",
      "transaction_type": "S",
      "shares_after_transaction": "29333.0000"
    },
    {
      "id": 279985,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-08-20",
      "transaction_shares": "1250.0000",
      "transaction_price": "69.9501",
      "transaction_type": "S",
      "shares_after_transaction": "29333.0000"
    },
    {
      "id": 323146,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-08-20",
      "transaction_shares": "1250.0000",
      "transaction_price": "69.9501",
      "transaction_type": "S",
      "shares_after_transaction": "29333.0000"
    },
    {
      "id": 369823,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-08-20",
      "transaction_shares": "1250.0000",
      "transaction_price": "69.9501",
      "transaction_type": "S",
      "shares_after_transaction": "29333.0000"
    },
    {
      "id": 95904,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-08-14",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 120816,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-08-14",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 147727,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-08-14",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 176728,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-08-14",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 208215,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-08-14",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 242220,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-08-14",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 280007,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-08-14",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 323168,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-08-14",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 369846,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-08-14",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 73154,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-07-11",
      "transaction_shares": "500.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "23689.0651"
    },
    {
      "id": 95938,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-07-11",
      "transaction_shares": "500.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "23689.0651"
    },
    {
      "id": 120850,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-07-11",
      "transaction_shares": "500.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "23689.0651"
    },
    {
      "id": 147761,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-07-11",
      "transaction_shares": "500.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "23689.0651"
    },
    {
      "id": 176763,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-07-11",
      "transaction_shares": "500.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "23689.0651"
    },
    {
      "id": 208253,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-07-11",
      "transaction_shares": "500.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "23689.0651"
    },
    {
      "id": 242260,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-07-11",
      "transaction_shares": "500.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "23689.0651"
    },
    {
      "id": 280049,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-07-11",
      "transaction_shares": "500.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "23689.0651"
    },
    {
      "id": 323213,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-07-11",
      "transaction_shares": "500.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "23689.0651"
    },
    {
      "id": 369892,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-07-11",
      "transaction_shares": "500.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "23689.0651"
    },
    {
      "id": 73114,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-07-10",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 73144,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Feinberg David T",
      "reporting_owner_cik": "0001486426",
      "reporting_owner_position": null,
      "transaction_date": "2024-07-10",
      "transaction_shares": "2308.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "2308.0000"
    },
    {
      "id": 95897,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-07-10",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 95928,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Feinberg David T",
      "reporting_owner_cik": "0001486426",
      "reporting_owner_position": null,
      "transaction_date": "2024-07-10",
      "transaction_shares": "2308.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "2308.0000"
    },
    {
      "id": 120809,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-07-10",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 120840,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Feinberg David T",
      "reporting_owner_cik": "0001486426",
      "reporting_owner_position": null,
      "transaction_date": "2024-07-10",
      "transaction_shares": "2308.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "2308.0000"
    },
    {
      "id": 147720,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-07-10",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 147751,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Feinberg David T",
      "reporting_owner_cik": "0001486426",
      "reporting_owner_position": null,
      "transaction_date": "2024-07-10",
      "transaction_shares": "2308.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "2308.0000"
    },
    {
      "id": 176721,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-07-10",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 176752,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Feinberg David T",
      "reporting_owner_cik": "0001486426",
      "reporting_owner_position": null,
      "transaction_date": "2024-07-10",
      "transaction_shares": "2308.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "2308.0000"
    },
    {
      "id": 208208,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-07-10",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 208241,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Feinberg David T",
      "reporting_owner_cik": "0001486426",
      "reporting_owner_position": null,
      "transaction_date": "2024-07-10",
      "transaction_shares": "2308.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "2308.0000"
    },
    {
      "id": 242213,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-07-10",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 242247,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Feinberg David T",
      "reporting_owner_cik": "0001486426",
      "reporting_owner_position": null,
      "transaction_date": "2024-07-10",
      "transaction_shares": "2308.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "2308.0000"
    },
    {
      "id": 279998,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-07-10",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 280036,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Feinberg David T",
      "reporting_owner_cik": "0001486426",
      "reporting_owner_position": null,
      "transaction_date": "2024-07-10",
      "transaction_shares": "2308.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "2308.0000"
    },
    {
      "id": 323159,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-07-10",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 323200,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Feinberg David T",
      "reporting_owner_cik": "0001486426",
      "reporting_owner_position": null,
      "transaction_date": "2024-07-10",
      "transaction_shares": "2308.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "2308.0000"
    },
    {
      "id": 369837,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-07-10",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 369879,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Feinberg David T",
      "reporting_owner_cik": "0001486426",
      "reporting_owner_position": null,
      "transaction_date": "2024-07-10",
      "transaction_shares": "2308.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "2308.0000"
    },
    {
      "id": 73100,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-07-07",
      "transaction_shares": "82.0000",
      "transaction_price": "92.3200",
      "transaction_type": "F",
      "shares_after_transaction": "184685.8054"
    },
    {
      "id": 73119,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-07-07",
      "transaction_shares": "410.0000",
      "transaction_price": "92.3200",
      "transaction_type": "F",
      "shares_after_transaction": "23189.0651"
    },
    {
      "id": 73132,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-07-07",
      "transaction_shares": "258.0000",
      "transaction_price": "92.3200",
      "transaction_type": "F",
      "shares_after_transaction": "75907.4373"
    },
    {
      "id": 95882,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-07-07",
      "transaction_shares": "82.0000",
      "transaction_price": "92.3200",
      "transaction_type": "F",
      "shares_after_transaction": "184685.8054"
    },
    {
      "id": 95902,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-07-07",
      "transaction_shares": "410.0000",
      "transaction_price": "92.3200",
      "transaction_type": "F",
      "shares_after_transaction": "23189.0651"
    },
    {
      "id": 95916,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-07-07",
      "transaction_shares": "258.0000",
      "transaction_price": "92.3200",
      "transaction_type": "F",
      "shares_after_transaction": "75907.4373"
    },
    {
      "id": 120793,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-07-07",
      "transaction_shares": "82.0000",
      "transaction_price": "92.3200",
      "transaction_type": "F",
      "shares_after_transaction": "184685.8054"
    },
    {
      "id": 120814,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-07-07",
      "transaction_shares": "410.0000",
      "transaction_price": "92.3200",
      "transaction_type": "F",
      "shares_after_transaction": "23189.0651"
    },
    {
      "id": 120828,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-07-07",
      "transaction_shares": "258.0000",
      "transaction_price": "92.3200",
      "transaction_type": "F",
      "shares_after_transaction": "75907.4373"
    },
    {
      "id": 147703,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-07-07",
      "transaction_shares": "82.0000",
      "transaction_price": "92.3200",
      "transaction_type": "F",
      "shares_after_transaction": "184685.8054"
    },
    {
      "id": 147725,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-07-07",
      "transaction_shares": "410.0000",
      "transaction_price": "92.3200",
      "transaction_type": "F",
      "shares_after_transaction": "23189.0651"
    },
    {
      "id": 147739,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-07-07",
      "transaction_shares": "258.0000",
      "transaction_price": "92.3200",
      "transaction_type": "F",
      "shares_after_transaction": "75907.4373"
    },
    {
      "id": 176704,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-07-07",
      "transaction_shares": "82.0000",
      "transaction_price": "92.3200",
      "transaction_type": "F",
      "shares_after_transaction": "184685.8054"
    },
    {
      "id": 176726,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-07-07",
      "transaction_shares": "410.0000",
      "transaction_price": "92.3200",
      "transaction_type": "F",
      "shares_after_transaction": "23189.0651"
    },
    {
      "id": 176740,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-07-07",
      "transaction_shares": "258.0000",
      "transaction_price": "92.3200",
      "transaction_type": "F",
      "shares_after_transaction": "75907.4373"
    },
    {
      "id": 208190,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-07-07",
      "transaction_shares": "82.0000",
      "transaction_price": "92.3200",
      "transaction_type": "F",
      "shares_after_transaction": "184685.8054"
    },
    {
      "id": 208213,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-07-07",
      "transaction_shares": "410.0000",
      "transaction_price": "92.3200",
      "transaction_type": "F",
      "shares_after_transaction": "23189.0651"
    },
    {
      "id": 208228,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-07-07",
      "transaction_shares": "258.0000",
      "transaction_price": "92.3200",
      "transaction_type": "F",
      "shares_after_transaction": "75907.4373"
    },
    {
      "id": 242195,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-07-07",
      "transaction_shares": "82.0000",
      "transaction_price": "92.3200",
      "transaction_type": "F",
      "shares_after_transaction": "184685.8054"
    },
    {
      "id": 242218,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-07-07",
      "transaction_shares": "410.0000",
      "transaction_price": "92.3200",
      "transaction_type": "F",
      "shares_after_transaction": "23189.0651"
    },
    {
      "id": 242234,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-07-07",
      "transaction_shares": "258.0000",
      "transaction_price": "92.3200",
      "transaction_type": "F",
      "shares_after_transaction": "75907.4373"
    },
    {
      "id": 279977,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-07-07",
      "transaction_shares": "82.0000",
      "transaction_price": "92.3200",
      "transaction_type": "F",
      "shares_after_transaction": "184685.8054"
    },
    {
      "id": 280004,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-07-07",
      "transaction_shares": "410.0000",
      "transaction_price": "92.3200",
      "transaction_type": "F",
      "shares_after_transaction": "23189.0651"
    },
    {
      "id": 280022,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-07-07",
      "transaction_shares": "258.0000",
      "transaction_price": "92.3200",
      "transaction_type": "F",
      "shares_after_transaction": "75907.4373"
    },
    {
      "id": 323138,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-07-07",
      "transaction_shares": "82.0000",
      "transaction_price": "92.3200",
      "transaction_type": "F",
      "shares_after_transaction": "184685.8054"
    },
    {
      "id": 323165,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-07-07",
      "transaction_shares": "410.0000",
      "transaction_price": "92.3200",
      "transaction_type": "F",
      "shares_after_transaction": "23189.0651"
    },
    {
      "id": 323184,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-07-07",
      "transaction_shares": "258.0000",
      "transaction_price": "92.3200",
      "transaction_type": "F",
      "shares_after_transaction": "75907.4373"
    },
    {
      "id": 369815,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-07-07",
      "transaction_shares": "82.0000",
      "transaction_price": "92.3200",
      "transaction_type": "F",
      "shares_after_transaction": "184685.8054"
    },
    {
      "id": 369843,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-07-07",
      "transaction_shares": "410.0000",
      "transaction_price": "92.3200",
      "transaction_type": "F",
      "shares_after_transaction": "23189.0651"
    },
    {
      "id": 369862,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-07-07",
      "transaction_shares": "258.0000",
      "transaction_price": "92.3200",
      "transaction_type": "F",
      "shares_after_transaction": "75907.4373"
    },
    {
      "id": 52476,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-06-20",
      "transaction_shares": "535.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "24047.7443"
    },
    {
      "id": 52482,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-06-20",
      "transaction_shares": "5625.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "36186.0000"
    },
    {
      "id": 73137,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-06-20",
      "transaction_shares": "535.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "24047.7443"
    },
    {
      "id": 73143,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-06-20",
      "transaction_shares": "5625.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "36186.0000"
    },
    {
      "id": 95921,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-06-20",
      "transaction_shares": "535.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "24047.7443"
    },
    {
      "id": 95927,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-06-20",
      "transaction_shares": "5625.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "36186.0000"
    },
    {
      "id": 120833,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-06-20",
      "transaction_shares": "535.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "24047.7443"
    },
    {
      "id": 120839,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-06-20",
      "transaction_shares": "5625.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "36186.0000"
    },
    {
      "id": 147744,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-06-20",
      "transaction_shares": "535.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "24047.7443"
    },
    {
      "id": 147750,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-06-20",
      "transaction_shares": "5625.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "36186.0000"
    },
    {
      "id": 176745,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-06-20",
      "transaction_shares": "535.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "24047.7443"
    },
    {
      "id": 176751,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-06-20",
      "transaction_shares": "5625.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "36186.0000"
    },
    {
      "id": 208234,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-06-20",
      "transaction_shares": "535.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "24047.7443"
    },
    {
      "id": 208240,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-06-20",
      "transaction_shares": "5625.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "36186.0000"
    },
    {
      "id": 242240,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-06-20",
      "transaction_shares": "535.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "24047.7443"
    },
    {
      "id": 242246,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-06-20",
      "transaction_shares": "5625.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "36186.0000"
    },
    {
      "id": 280028,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-06-20",
      "transaction_shares": "535.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "24047.7443"
    },
    {
      "id": 280035,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-06-20",
      "transaction_shares": "5625.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "36186.0000"
    },
    {
      "id": 323192,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-06-20",
      "transaction_shares": "535.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "24047.7443"
    },
    {
      "id": 323199,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-06-20",
      "transaction_shares": "5625.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "36186.0000"
    },
    {
      "id": 369871,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-06-20",
      "transaction_shares": "535.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "24047.7443"
    },
    {
      "id": 369878,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-06-20",
      "transaction_shares": "5625.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "36186.0000"
    },
    {
      "id": 52429,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-06-12",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 73086,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-06-12",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 95868,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-06-12",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 120776,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-06-12",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 147686,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-06-12",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 176687,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-06-12",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 208172,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-06-12",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 242177,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-06-12",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 279956,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-06-12",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 323116,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-06-12",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 369793,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-06-12",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "51935.7184"
    },
    {
      "id": 52479,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-30",
      "transaction_shares": "8617.0000",
      "transaction_price": "87.6800",
      "transaction_type": "S",
      "shares_after_transaction": "68217.9005"
    },
    {
      "id": 73140,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-30",
      "transaction_shares": "8617.0000",
      "transaction_price": "87.6800",
      "transaction_type": "S",
      "shares_after_transaction": "68217.9005"
    },
    {
      "id": 95924,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-30",
      "transaction_shares": "8617.0000",
      "transaction_price": "87.6800",
      "transaction_type": "S",
      "shares_after_transaction": "68217.9005"
    },
    {
      "id": 120836,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-30",
      "transaction_shares": "8617.0000",
      "transaction_price": "87.6800",
      "transaction_type": "S",
      "shares_after_transaction": "68217.9005"
    },
    {
      "id": 147747,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-30",
      "transaction_shares": "8617.0000",
      "transaction_price": "87.6800",
      "transaction_type": "S",
      "shares_after_transaction": "68217.9005"
    },
    {
      "id": 176748,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-30",
      "transaction_shares": "8617.0000",
      "transaction_price": "87.6800",
      "transaction_type": "S",
      "shares_after_transaction": "68217.9005"
    },
    {
      "id": 208237,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-30",
      "transaction_shares": "8617.0000",
      "transaction_price": "87.6800",
      "transaction_type": "S",
      "shares_after_transaction": "68217.9005"
    },
    {
      "id": 242243,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-30",
      "transaction_shares": "8617.0000",
      "transaction_price": "87.6800",
      "transaction_type": "S",
      "shares_after_transaction": "68217.9005"
    },
    {
      "id": 280032,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-30",
      "transaction_shares": "8617.0000",
      "transaction_price": "87.6800",
      "transaction_type": "S",
      "shares_after_transaction": "68217.9005"
    },
    {
      "id": 323196,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-30",
      "transaction_shares": "8617.0000",
      "transaction_price": "87.6800",
      "transaction_type": "S",
      "shares_after_transaction": "68217.9005"
    },
    {
      "id": 369875,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-30",
      "transaction_shares": "8617.0000",
      "transaction_price": "87.6800",
      "transaction_type": "S",
      "shares_after_transaction": "68217.9005"
    },
    {
      "id": 34262,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-21",
      "transaction_shares": "5625.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "36186.0000"
    },
    {
      "id": 52427,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-21",
      "transaction_shares": "5625.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "36186.0000"
    },
    {
      "id": 73084,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-21",
      "transaction_shares": "5625.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "36186.0000"
    },
    {
      "id": 95866,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-21",
      "transaction_shares": "5625.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "36186.0000"
    },
    {
      "id": 120774,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-21",
      "transaction_shares": "5625.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "36186.0000"
    },
    {
      "id": 147684,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-21",
      "transaction_shares": "5625.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "36186.0000"
    },
    {
      "id": 176685,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-21",
      "transaction_shares": "5625.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "36186.0000"
    },
    {
      "id": 208170,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-21",
      "transaction_shares": "5625.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "36186.0000"
    },
    {
      "id": 242175,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-21",
      "transaction_shares": "5625.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "36186.0000"
    },
    {
      "id": 279954,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-21",
      "transaction_shares": "5625.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "36186.0000"
    },
    {
      "id": 323114,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-21",
      "transaction_shares": "5625.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "36186.0000"
    },
    {
      "id": 369791,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-21",
      "transaction_shares": "5625.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "36186.0000"
    },
    {
      "id": 34263,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-05-11",
      "transaction_shares": "229.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "17081.1980"
    },
    {
      "id": 34268,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-11",
      "transaction_shares": "2854.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "76834.9005"
    },
    {
      "id": 34272,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-11",
      "transaction_shares": "21.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "184767.8055"
    },
    {
      "id": 34286,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-05-11",
      "transaction_shares": "985.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "223525.7390"
    },
    {
      "id": 34298,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-11",
      "transaction_shares": "1198.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "30561.0000"
    },
    {
      "id": 34299,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-05-11",
      "transaction_shares": "827.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "76165.4373"
    },
    {
      "id": 34306,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-05-11",
      "transaction_shares": "821.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "30583.0000"
    },
    {
      "id": 34320,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-05-11",
      "transaction_shares": "377.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "23512.7443"
    },
    {
      "id": 52428,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-05-11",
      "transaction_shares": "229.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "17081.1980"
    },
    {
      "id": 52434,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-11",
      "transaction_shares": "2854.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "76834.9005"
    },
    {
      "id": 52438,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-11",
      "transaction_shares": "21.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "184767.8055"
    },
    {
      "id": 52452,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-05-11",
      "transaction_shares": "985.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "223525.7390"
    },
    {
      "id": 52464,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-11",
      "transaction_shares": "1198.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "30561.0000"
    },
    {
      "id": 52465,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-05-11",
      "transaction_shares": "827.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "76165.4373"
    },
    {
      "id": 52472,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-05-11",
      "transaction_shares": "821.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "30583.0000"
    },
    {
      "id": 52489,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-05-11",
      "transaction_shares": "377.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "23512.7443"
    },
    {
      "id": 73085,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-05-11",
      "transaction_shares": "229.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "17081.1980"
    },
    {
      "id": 73091,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-11",
      "transaction_shares": "2854.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "76834.9005"
    },
    {
      "id": 73095,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-11",
      "transaction_shares": "21.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "184767.8055"
    },
    {
      "id": 73110,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-05-11",
      "transaction_shares": "985.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "223525.7390"
    },
    {
      "id": 73124,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-11",
      "transaction_shares": "1198.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "30561.0000"
    },
    {
      "id": 73125,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-05-11",
      "transaction_shares": "827.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "76165.4373"
    },
    {
      "id": 73133,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-05-11",
      "transaction_shares": "821.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "30583.0000"
    },
    {
      "id": 73151,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-05-11",
      "transaction_shares": "377.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "23512.7443"
    },
    {
      "id": 95867,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-05-11",
      "transaction_shares": "229.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "17081.1980"
    },
    {
      "id": 95873,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-11",
      "transaction_shares": "2854.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "76834.9005"
    },
    {
      "id": 95877,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-11",
      "transaction_shares": "21.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "184767.8055"
    },
    {
      "id": 95893,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-05-11",
      "transaction_shares": "985.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "223525.7390"
    },
    {
      "id": 95908,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-11",
      "transaction_shares": "1198.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "30561.0000"
    },
    {
      "id": 95909,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-05-11",
      "transaction_shares": "827.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "76165.4373"
    },
    {
      "id": 95917,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-05-11",
      "transaction_shares": "821.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "30583.0000"
    },
    {
      "id": 95935,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-05-11",
      "transaction_shares": "377.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "23512.7443"
    },
    {
      "id": 120775,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-05-11",
      "transaction_shares": "229.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "17081.1980"
    },
    {
      "id": 120783,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-11",
      "transaction_shares": "2854.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "76834.9005"
    },
    {
      "id": 120787,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-11",
      "transaction_shares": "21.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "184767.8055"
    },
    {
      "id": 120805,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-05-11",
      "transaction_shares": "985.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "223525.7390"
    },
    {
      "id": 120820,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-11",
      "transaction_shares": "1198.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "30561.0000"
    },
    {
      "id": 120821,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-05-11",
      "transaction_shares": "827.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "76165.4373"
    },
    {
      "id": 120829,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-05-11",
      "transaction_shares": "821.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "30583.0000"
    },
    {
      "id": 120847,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-05-11",
      "transaction_shares": "377.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "23512.7443"
    },
    {
      "id": 147685,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-05-11",
      "transaction_shares": "229.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "17081.1980"
    },
    {
      "id": 147693,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-11",
      "transaction_shares": "2854.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "76834.9005"
    },
    {
      "id": 147697,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-11",
      "transaction_shares": "21.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "184767.8055"
    },
    {
      "id": 147716,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-05-11",
      "transaction_shares": "985.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "223525.7390"
    },
    {
      "id": 147731,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-11",
      "transaction_shares": "1198.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "30561.0000"
    },
    {
      "id": 147732,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-05-11",
      "transaction_shares": "827.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "76165.4373"
    },
    {
      "id": 147740,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-05-11",
      "transaction_shares": "821.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "30583.0000"
    },
    {
      "id": 147758,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-05-11",
      "transaction_shares": "377.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "23512.7443"
    },
    {
      "id": 176686,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-05-11",
      "transaction_shares": "229.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "17081.1980"
    },
    {
      "id": 176694,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-11",
      "transaction_shares": "2854.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "76834.9005"
    },
    {
      "id": 176698,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-11",
      "transaction_shares": "21.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "184767.8055"
    },
    {
      "id": 176717,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-05-11",
      "transaction_shares": "985.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "223525.7390"
    },
    {
      "id": 176732,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-11",
      "transaction_shares": "1198.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "30561.0000"
    },
    {
      "id": 176733,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-05-11",
      "transaction_shares": "827.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "76165.4373"
    },
    {
      "id": 176741,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-05-11",
      "transaction_shares": "821.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "30583.0000"
    },
    {
      "id": 176759,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-05-11",
      "transaction_shares": "377.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "23512.7443"
    },
    {
      "id": 208171,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-05-11",
      "transaction_shares": "229.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "17081.1980"
    },
    {
      "id": 208179,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-11",
      "transaction_shares": "2854.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "76834.9005"
    },
    {
      "id": 208183,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-11",
      "transaction_shares": "21.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "184767.8055"
    },
    {
      "id": 208204,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-05-11",
      "transaction_shares": "985.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "223525.7390"
    },
    {
      "id": 208219,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-11",
      "transaction_shares": "1198.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "30561.0000"
    },
    {
      "id": 208220,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-05-11",
      "transaction_shares": "827.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "76165.4373"
    },
    {
      "id": 208229,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-05-11",
      "transaction_shares": "821.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "30583.0000"
    },
    {
      "id": 208249,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-05-11",
      "transaction_shares": "377.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "23512.7443"
    },
    {
      "id": 242176,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-05-11",
      "transaction_shares": "229.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "17081.1980"
    },
    {
      "id": 242184,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-11",
      "transaction_shares": "2854.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "76834.9005"
    },
    {
      "id": 242188,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-11",
      "transaction_shares": "21.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "184767.8055"
    },
    {
      "id": 242209,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-05-11",
      "transaction_shares": "985.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "223525.7390"
    },
    {
      "id": 242224,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-11",
      "transaction_shares": "1198.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "30561.0000"
    },
    {
      "id": 242226,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-05-11",
      "transaction_shares": "827.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "76165.4373"
    },
    {
      "id": 242235,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-05-11",
      "transaction_shares": "821.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "30583.0000"
    },
    {
      "id": 242255,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-05-11",
      "transaction_shares": "377.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "23512.7443"
    },
    {
      "id": 279955,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-05-11",
      "transaction_shares": "229.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "17081.1980"
    },
    {
      "id": 279964,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-11",
      "transaction_shares": "2854.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "76834.9005"
    },
    {
      "id": 279969,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-11",
      "transaction_shares": "21.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "184767.8055"
    },
    {
      "id": 279994,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-05-11",
      "transaction_shares": "985.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "223525.7390"
    },
    {
      "id": 280011,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-11",
      "transaction_shares": "1198.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "30561.0000"
    },
    {
      "id": 280013,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-05-11",
      "transaction_shares": "827.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "76165.4373"
    },
    {
      "id": 280023,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-05-11",
      "transaction_shares": "821.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "30583.0000"
    },
    {
      "id": 280044,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-05-11",
      "transaction_shares": "377.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "23512.7443"
    },
    {
      "id": 323115,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-05-11",
      "transaction_shares": "229.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "17081.1980"
    },
    {
      "id": 323125,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-11",
      "transaction_shares": "2854.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "76834.9005"
    },
    {
      "id": 323130,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-11",
      "transaction_shares": "21.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "184767.8055"
    },
    {
      "id": 323155,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-05-11",
      "transaction_shares": "985.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "223525.7390"
    },
    {
      "id": 323172,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-11",
      "transaction_shares": "1198.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "30561.0000"
    },
    {
      "id": 323174,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-05-11",
      "transaction_shares": "827.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "76165.4373"
    },
    {
      "id": 323185,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-05-11",
      "transaction_shares": "821.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "30583.0000"
    },
    {
      "id": 323208,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-05-11",
      "transaction_shares": "377.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "23512.7443"
    },
    {
      "id": 369792,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-05-11",
      "transaction_shares": "229.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "17081.1980"
    },
    {
      "id": 369802,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-11",
      "transaction_shares": "2854.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "76834.9005"
    },
    {
      "id": 369807,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-11",
      "transaction_shares": "21.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "184767.8055"
    },
    {
      "id": 369833,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-05-11",
      "transaction_shares": "985.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "223525.7390"
    },
    {
      "id": 369850,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-11",
      "transaction_shares": "1198.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "30561.0000"
    },
    {
      "id": 369852,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-05-11",
      "transaction_shares": "827.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "76165.4373"
    },
    {
      "id": 369863,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-05-11",
      "transaction_shares": "821.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "30583.0000"
    },
    {
      "id": 369887,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-05-11",
      "transaction_shares": "377.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "23512.7443"
    },
    {
      "id": 34312,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-05-10",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "52749.7184"
    },
    {
      "id": 52480,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-05-10",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "52749.7184"
    },
    {
      "id": 73141,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-05-10",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "52749.7184"
    },
    {
      "id": 95925,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-05-10",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "52749.7184"
    },
    {
      "id": 120837,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-05-10",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "52749.7184"
    },
    {
      "id": 147748,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-05-10",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "52749.7184"
    },
    {
      "id": 176749,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-05-10",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "52749.7184"
    },
    {
      "id": 208238,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-05-10",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "52749.7184"
    },
    {
      "id": 242244,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-05-10",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "52749.7184"
    },
    {
      "id": 280033,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-05-10",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "52749.7184"
    },
    {
      "id": 323197,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-05-10",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "52749.7184"
    },
    {
      "id": 369876,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-05-10",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "52749.7184"
    },
    {
      "id": 34267,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Sequeira Ramona",
      "reporting_owner_cik": "0001811081",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "8158.0000"
    },
    {
      "id": 34284,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "GALLAHUE KIERAN",
      "reporting_owner_cik": "0001308428",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "3055.0000"
    },
    {
      "id": 34291,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LAVIOLETTE PAUL A",
      "reporting_owner_cik": "0001191249",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "10773.0000"
    },
    {
      "id": 34294,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "VALERIANI NICHOLAS J",
      "reporting_owner_cik": "0001263149",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "4818.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "73732.0000"
    },
    {
      "id": 34295,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Davis Leslie C.",
      "reporting_owner_cik": "0002021765",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "3055.0000"
    },
    {
      "id": 34314,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LORANGER STEVEN R",
      "reporting_owner_cik": "0001226924",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "59373.0000"
    },
    {
      "id": 34316,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "30035.0000"
    },
    {
      "id": 52433,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Sequeira Ramona",
      "reporting_owner_cik": "0001811081",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "8158.0000"
    },
    {
      "id": 52450,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "GALLAHUE KIERAN",
      "reporting_owner_cik": "0001308428",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "3055.0000"
    },
    {
      "id": 52457,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LAVIOLETTE PAUL A",
      "reporting_owner_cik": "0001191249",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "10773.0000"
    },
    {
      "id": 52460,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "VALERIANI NICHOLAS J",
      "reporting_owner_cik": "0001263149",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "4818.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "73732.0000"
    },
    {
      "id": 52461,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Davis Leslie C.",
      "reporting_owner_cik": "0002021765",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "3055.0000"
    },
    {
      "id": 52483,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LORANGER STEVEN R",
      "reporting_owner_cik": "0001226924",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "59373.0000"
    },
    {
      "id": 52485,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "30035.0000"
    },
    {
      "id": 73090,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Sequeira Ramona",
      "reporting_owner_cik": "0001811081",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "8158.0000"
    },
    {
      "id": 73108,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "GALLAHUE KIERAN",
      "reporting_owner_cik": "0001308428",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "3055.0000"
    },
    {
      "id": 73116,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LAVIOLETTE PAUL A",
      "reporting_owner_cik": "0001191249",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "10773.0000"
    },
    {
      "id": 73120,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "VALERIANI NICHOLAS J",
      "reporting_owner_cik": "0001263149",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "4818.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "73732.0000"
    },
    {
      "id": 73121,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Davis Leslie C.",
      "reporting_owner_cik": "0002021765",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "3055.0000"
    },
    {
      "id": 73145,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LORANGER STEVEN R",
      "reporting_owner_cik": "0001226924",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "59373.0000"
    },
    {
      "id": 73147,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "30035.0000"
    },
    {
      "id": 95872,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Sequeira Ramona",
      "reporting_owner_cik": "0001811081",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "8158.0000"
    },
    {
      "id": 95891,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "GALLAHUE KIERAN",
      "reporting_owner_cik": "0001308428",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "3055.0000"
    },
    {
      "id": 95899,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LAVIOLETTE PAUL A",
      "reporting_owner_cik": "0001191249",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "10773.0000"
    },
    {
      "id": 95903,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "VALERIANI NICHOLAS J",
      "reporting_owner_cik": "0001263149",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "4818.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "73732.0000"
    },
    {
      "id": 95905,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Davis Leslie C.",
      "reporting_owner_cik": "0002021765",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "3055.0000"
    },
    {
      "id": 95929,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LORANGER STEVEN R",
      "reporting_owner_cik": "0001226924",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "59373.0000"
    },
    {
      "id": 95931,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "30035.0000"
    },
    {
      "id": 120782,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Sequeira Ramona",
      "reporting_owner_cik": "0001811081",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "8158.0000"
    },
    {
      "id": 120803,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "GALLAHUE KIERAN",
      "reporting_owner_cik": "0001308428",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "3055.0000"
    },
    {
      "id": 120811,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LAVIOLETTE PAUL A",
      "reporting_owner_cik": "0001191249",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "10773.0000"
    },
    {
      "id": 120815,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "VALERIANI NICHOLAS J",
      "reporting_owner_cik": "0001263149",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "4818.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "73732.0000"
    },
    {
      "id": 120817,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Davis Leslie C.",
      "reporting_owner_cik": "0002021765",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "3055.0000"
    },
    {
      "id": 120841,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LORANGER STEVEN R",
      "reporting_owner_cik": "0001226924",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "59373.0000"
    },
    {
      "id": 120843,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "30035.0000"
    },
    {
      "id": 147692,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Sequeira Ramona",
      "reporting_owner_cik": "0001811081",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "8158.0000"
    },
    {
      "id": 147714,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "GALLAHUE KIERAN",
      "reporting_owner_cik": "0001308428",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "3055.0000"
    },
    {
      "id": 147722,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LAVIOLETTE PAUL A",
      "reporting_owner_cik": "0001191249",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "10773.0000"
    },
    {
      "id": 147726,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "VALERIANI NICHOLAS J",
      "reporting_owner_cik": "0001263149",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "4818.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "73732.0000"
    },
    {
      "id": 147728,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Davis Leslie C.",
      "reporting_owner_cik": "0002021765",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "3055.0000"
    },
    {
      "id": 147752,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LORANGER STEVEN R",
      "reporting_owner_cik": "0001226924",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "59373.0000"
    },
    {
      "id": 147754,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "30035.0000"
    },
    {
      "id": 176693,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Sequeira Ramona",
      "reporting_owner_cik": "0001811081",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "8158.0000"
    },
    {
      "id": 176715,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "GALLAHUE KIERAN",
      "reporting_owner_cik": "0001308428",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "3055.0000"
    },
    {
      "id": 176723,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LAVIOLETTE PAUL A",
      "reporting_owner_cik": "0001191249",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "10773.0000"
    },
    {
      "id": 176727,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "VALERIANI NICHOLAS J",
      "reporting_owner_cik": "0001263149",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "4818.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "73732.0000"
    },
    {
      "id": 176729,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Davis Leslie C.",
      "reporting_owner_cik": "0002021765",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "3055.0000"
    },
    {
      "id": 176753,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LORANGER STEVEN R",
      "reporting_owner_cik": "0001226924",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "59373.0000"
    },
    {
      "id": 176755,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "30035.0000"
    },
    {
      "id": 208178,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Sequeira Ramona",
      "reporting_owner_cik": "0001811081",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "8158.0000"
    },
    {
      "id": 208202,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "GALLAHUE KIERAN",
      "reporting_owner_cik": "0001308428",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "3055.0000"
    },
    {
      "id": 208210,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LAVIOLETTE PAUL A",
      "reporting_owner_cik": "0001191249",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "10773.0000"
    },
    {
      "id": 208214,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "VALERIANI NICHOLAS J",
      "reporting_owner_cik": "0001263149",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "4818.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "73732.0000"
    },
    {
      "id": 208216,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Davis Leslie C.",
      "reporting_owner_cik": "0002021765",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "3055.0000"
    },
    {
      "id": 208242,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LORANGER STEVEN R",
      "reporting_owner_cik": "0001226924",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "59373.0000"
    },
    {
      "id": 208245,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "30035.0000"
    },
    {
      "id": 242183,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Sequeira Ramona",
      "reporting_owner_cik": "0001811081",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "8158.0000"
    },
    {
      "id": 242207,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "GALLAHUE KIERAN",
      "reporting_owner_cik": "0001308428",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "3055.0000"
    },
    {
      "id": 242215,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LAVIOLETTE PAUL A",
      "reporting_owner_cik": "0001191249",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "10773.0000"
    },
    {
      "id": 242219,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "VALERIANI NICHOLAS J",
      "reporting_owner_cik": "0001263149",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "4818.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "73732.0000"
    },
    {
      "id": 242221,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Davis Leslie C.",
      "reporting_owner_cik": "0002021765",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "3055.0000"
    },
    {
      "id": 242248,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LORANGER STEVEN R",
      "reporting_owner_cik": "0001226924",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "59373.0000"
    },
    {
      "id": 242251,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "30035.0000"
    },
    {
      "id": 279962,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Sequeira Ramona",
      "reporting_owner_cik": "0001811081",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "8158.0000"
    },
    {
      "id": 279991,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "GALLAHUE KIERAN",
      "reporting_owner_cik": "0001308428",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "3055.0000"
    },
    {
      "id": 280000,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LAVIOLETTE PAUL A",
      "reporting_owner_cik": "0001191249",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "10773.0000"
    },
    {
      "id": 280006,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "VALERIANI NICHOLAS J",
      "reporting_owner_cik": "0001263149",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "4818.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "73732.0000"
    },
    {
      "id": 280008,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Davis Leslie C.",
      "reporting_owner_cik": "0002021765",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "3055.0000"
    },
    {
      "id": 280037,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LORANGER STEVEN R",
      "reporting_owner_cik": "0001226924",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "59373.0000"
    },
    {
      "id": 280040,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "30035.0000"
    },
    {
      "id": 323123,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Sequeira Ramona",
      "reporting_owner_cik": "0001811081",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "8158.0000"
    },
    {
      "id": 323152,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "GALLAHUE KIERAN",
      "reporting_owner_cik": "0001308428",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "3055.0000"
    },
    {
      "id": 323161,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LAVIOLETTE PAUL A",
      "reporting_owner_cik": "0001191249",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "10773.0000"
    },
    {
      "id": 323167,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "VALERIANI NICHOLAS J",
      "reporting_owner_cik": "0001263149",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "4818.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "73732.0000"
    },
    {
      "id": 323169,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Davis Leslie C.",
      "reporting_owner_cik": "0002021765",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "3055.0000"
    },
    {
      "id": 323201,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LORANGER STEVEN R",
      "reporting_owner_cik": "0001226924",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "59373.0000"
    },
    {
      "id": 323204,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "30035.0000"
    },
    {
      "id": 369800,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Sequeira Ramona",
      "reporting_owner_cik": "0001811081",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "8158.0000"
    },
    {
      "id": 369829,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "GALLAHUE KIERAN",
      "reporting_owner_cik": "0001308428",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "3055.0000"
    },
    {
      "id": 369839,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LAVIOLETTE PAUL A",
      "reporting_owner_cik": "0001191249",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "10773.0000"
    },
    {
      "id": 369845,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "VALERIANI NICHOLAS J",
      "reporting_owner_cik": "0001263149",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "4818.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "73732.0000"
    },
    {
      "id": 369847,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Davis Leslie C.",
      "reporting_owner_cik": "0002021765",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "3055.0000"
    },
    {
      "id": 369880,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LORANGER STEVEN R",
      "reporting_owner_cik": "0001226924",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "59373.0000"
    },
    {
      "id": 369883,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "30035.0000"
    },
    {
      "id": 34266,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-05-07",
      "transaction_shares": "8725.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "225205.7390"
    },
    {
      "id": 34271,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-05-07",
      "transaction_shares": "6700.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "48368.7184"
    },
    {
      "id": 34277,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-07",
      "transaction_shares": "7125.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "184834.8055"
    },
    {
      "id": 34282,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-07",
      "transaction_shares": "33500.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "80335.9005"
    },
    {
      "id": 34304,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-05-07",
      "transaction_shares": "7000.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "31851.0000"
    },
    {
      "id": 34310,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-05-07",
      "transaction_shares": "4660.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "21575.7443"
    },
    {
      "id": 34311,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Markowitz Wayne",
      "reporting_owner_cik": "0001991414",
      "reporting_owner_position": "GM & SVP, Surgical",
      "transaction_date": "2024-05-07",
      "transaction_shares": "3350.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "10648.5547"
    },
    {
      "id": 34313,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-05-07",
      "transaction_shares": "32025.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "77601.4373"
    },
    {
      "id": 34318,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-07",
      "transaction_shares": "11075.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "32549.0000"
    },
    {
      "id": 34321,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-05-07",
      "transaction_shares": "2445.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "17488.1980"
    },
    {
      "id": 52432,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-05-07",
      "transaction_shares": "8725.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "225205.7390"
    },
    {
      "id": 52437,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-05-07",
      "transaction_shares": "6700.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "48368.7184"
    },
    {
      "id": 52443,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-07",
      "transaction_shares": "7125.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "184834.8055"
    },
    {
      "id": 52448,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-07",
      "transaction_shares": "33500.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "80335.9005"
    },
    {
      "id": 52470,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-05-07",
      "transaction_shares": "7000.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "31851.0000"
    },
    {
      "id": 52477,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-05-07",
      "transaction_shares": "4660.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "21575.7443"
    },
    {
      "id": 52478,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Markowitz Wayne",
      "reporting_owner_cik": "0001991414",
      "reporting_owner_position": "GM & SVP, Surgical",
      "transaction_date": "2024-05-07",
      "transaction_shares": "3350.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "10648.5547"
    },
    {
      "id": 52481,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-05-07",
      "transaction_shares": "32025.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "77601.4373"
    },
    {
      "id": 52487,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-07",
      "transaction_shares": "11075.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "32549.0000"
    },
    {
      "id": 52490,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-05-07",
      "transaction_shares": "2445.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "17488.1980"
    },
    {
      "id": 73089,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-05-07",
      "transaction_shares": "8725.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "225205.7390"
    },
    {
      "id": 73094,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-05-07",
      "transaction_shares": "6700.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "48368.7184"
    },
    {
      "id": 73101,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-07",
      "transaction_shares": "7125.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "184834.8055"
    },
    {
      "id": 73106,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-07",
      "transaction_shares": "33500.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "80335.9005"
    },
    {
      "id": 73130,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-05-07",
      "transaction_shares": "7000.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "31851.0000"
    },
    {
      "id": 73138,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-05-07",
      "transaction_shares": "4660.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "21575.7443"
    },
    {
      "id": 73139,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Markowitz Wayne",
      "reporting_owner_cik": "0001991414",
      "reporting_owner_position": "GM & SVP, Surgical",
      "transaction_date": "2024-05-07",
      "transaction_shares": "3350.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "10648.5547"
    },
    {
      "id": 73142,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-05-07",
      "transaction_shares": "32025.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "77601.4373"
    },
    {
      "id": 73149,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-07",
      "transaction_shares": "11075.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "32549.0000"
    },
    {
      "id": 73152,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-05-07",
      "transaction_shares": "2445.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "17488.1980"
    },
    {
      "id": 95871,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-05-07",
      "transaction_shares": "8725.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "225205.7390"
    },
    {
      "id": 95876,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-05-07",
      "transaction_shares": "6700.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "48368.7184"
    },
    {
      "id": 95883,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-07",
      "transaction_shares": "7125.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "184834.8055"
    },
    {
      "id": 95889,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-07",
      "transaction_shares": "33500.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "80335.9005"
    },
    {
      "id": 95914,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-05-07",
      "transaction_shares": "7000.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "31851.0000"
    },
    {
      "id": 95922,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-05-07",
      "transaction_shares": "4660.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "21575.7443"
    },
    {
      "id": 95923,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Markowitz Wayne",
      "reporting_owner_cik": "0001991414",
      "reporting_owner_position": "GM & SVP, Surgical",
      "transaction_date": "2024-05-07",
      "transaction_shares": "3350.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "10648.5547"
    },
    {
      "id": 95926,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-05-07",
      "transaction_shares": "32025.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "77601.4373"
    },
    {
      "id": 95933,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-07",
      "transaction_shares": "11075.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "32549.0000"
    },
    {
      "id": 95936,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-05-07",
      "transaction_shares": "2445.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "17488.1980"
    },
    {
      "id": 120780,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-05-07",
      "transaction_shares": "8725.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "225205.7390"
    },
    {
      "id": 120786,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-05-07",
      "transaction_shares": "6700.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "48368.7184"
    },
    {
      "id": 120794,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-07",
      "transaction_shares": "7125.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "184834.8055"
    },
    {
      "id": 120801,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-07",
      "transaction_shares": "33500.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "80335.9005"
    },
    {
      "id": 120826,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-05-07",
      "transaction_shares": "7000.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "31851.0000"
    },
    {
      "id": 120834,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-05-07",
      "transaction_shares": "4660.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "21575.7443"
    },
    {
      "id": 120835,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Markowitz Wayne",
      "reporting_owner_cik": "0001991414",
      "reporting_owner_position": "GM & SVP, Surgical",
      "transaction_date": "2024-05-07",
      "transaction_shares": "3350.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "10648.5547"
    },
    {
      "id": 120838,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-05-07",
      "transaction_shares": "32025.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "77601.4373"
    },
    {
      "id": 120845,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-07",
      "transaction_shares": "11075.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "32549.0000"
    },
    {
      "id": 120848,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-05-07",
      "transaction_shares": "2445.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "17488.1980"
    },
    {
      "id": 147690,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-05-07",
      "transaction_shares": "8725.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "225205.7390"
    },
    {
      "id": 147696,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-05-07",
      "transaction_shares": "6700.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "48368.7184"
    },
    {
      "id": 147704,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-07",
      "transaction_shares": "7125.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "184834.8055"
    },
    {
      "id": 147712,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-07",
      "transaction_shares": "33500.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "80335.9005"
    },
    {
      "id": 147737,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-05-07",
      "transaction_shares": "7000.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "31851.0000"
    },
    {
      "id": 147745,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-05-07",
      "transaction_shares": "4660.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "21575.7443"
    },
    {
      "id": 147746,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Markowitz Wayne",
      "reporting_owner_cik": "0001991414",
      "reporting_owner_position": "GM & SVP, Surgical",
      "transaction_date": "2024-05-07",
      "transaction_shares": "3350.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "10648.5547"
    },
    {
      "id": 147749,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-05-07",
      "transaction_shares": "32025.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "77601.4373"
    },
    {
      "id": 147756,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-07",
      "transaction_shares": "11075.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "32549.0000"
    },
    {
      "id": 147759,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-05-07",
      "transaction_shares": "2445.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "17488.1980"
    },
    {
      "id": 176691,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-05-07",
      "transaction_shares": "8725.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "225205.7390"
    },
    {
      "id": 176697,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-05-07",
      "transaction_shares": "6700.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "48368.7184"
    },
    {
      "id": 176705,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-07",
      "transaction_shares": "7125.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "184834.8055"
    },
    {
      "id": 176713,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-07",
      "transaction_shares": "33500.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "80335.9005"
    },
    {
      "id": 176738,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-05-07",
      "transaction_shares": "7000.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "31851.0000"
    },
    {
      "id": 176746,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-05-07",
      "transaction_shares": "4660.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "21575.7443"
    },
    {
      "id": 176747,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Markowitz Wayne",
      "reporting_owner_cik": "0001991414",
      "reporting_owner_position": "GM & SVP, Surgical",
      "transaction_date": "2024-05-07",
      "transaction_shares": "3350.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "10648.5547"
    },
    {
      "id": 176750,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-05-07",
      "transaction_shares": "32025.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "77601.4373"
    },
    {
      "id": 176757,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-07",
      "transaction_shares": "11075.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "32549.0000"
    },
    {
      "id": 176761,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-05-07",
      "transaction_shares": "2445.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "17488.1980"
    },
    {
      "id": 208176,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-05-07",
      "transaction_shares": "8725.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "225205.7390"
    },
    {
      "id": 208182,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-05-07",
      "transaction_shares": "6700.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "48368.7184"
    },
    {
      "id": 208191,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-07",
      "transaction_shares": "7125.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "184834.8055"
    },
    {
      "id": 208200,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-07",
      "transaction_shares": "33500.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "80335.9005"
    },
    {
      "id": 208226,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-05-07",
      "transaction_shares": "7000.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "31851.0000"
    },
    {
      "id": 208235,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-05-07",
      "transaction_shares": "4660.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "21575.7443"
    },
    {
      "id": 208236,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Markowitz Wayne",
      "reporting_owner_cik": "0001991414",
      "reporting_owner_position": "GM & SVP, Surgical",
      "transaction_date": "2024-05-07",
      "transaction_shares": "3350.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "10648.5547"
    },
    {
      "id": 208239,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-05-07",
      "transaction_shares": "32025.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "77601.4373"
    },
    {
      "id": 208247,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-07",
      "transaction_shares": "11075.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "32549.0000"
    },
    {
      "id": 208251,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-05-07",
      "transaction_shares": "2445.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "17488.1980"
    },
    {
      "id": 242181,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-05-07",
      "transaction_shares": "8725.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "225205.7390"
    },
    {
      "id": 242187,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-05-07",
      "transaction_shares": "6700.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "48368.7184"
    },
    {
      "id": 242196,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-07",
      "transaction_shares": "7125.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "184834.8055"
    },
    {
      "id": 242205,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-07",
      "transaction_shares": "33500.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "80335.9005"
    },
    {
      "id": 242232,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-05-07",
      "transaction_shares": "7000.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "31851.0000"
    },
    {
      "id": 242241,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-05-07",
      "transaction_shares": "4660.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "21575.7443"
    },
    {
      "id": 242242,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Markowitz Wayne",
      "reporting_owner_cik": "0001991414",
      "reporting_owner_position": "GM & SVP, Surgical",
      "transaction_date": "2024-05-07",
      "transaction_shares": "3350.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "10648.5547"
    },
    {
      "id": 242245,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-05-07",
      "transaction_shares": "32025.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "77601.4373"
    },
    {
      "id": 242253,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-07",
      "transaction_shares": "11075.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "32549.0000"
    },
    {
      "id": 242258,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-05-07",
      "transaction_shares": "2445.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "17488.1980"
    },
    {
      "id": 279960,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-05-07",
      "transaction_shares": "8725.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "225205.7390"
    },
    {
      "id": 279968,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-05-07",
      "transaction_shares": "6700.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "48368.7184"
    },
    {
      "id": 279978,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-07",
      "transaction_shares": "7125.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "184834.8055"
    },
    {
      "id": 279988,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-07",
      "transaction_shares": "33500.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "80335.9005"
    },
    {
      "id": 280020,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-05-07",
      "transaction_shares": "7000.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "31851.0000"
    },
    {
      "id": 280030,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-05-07",
      "transaction_shares": "4660.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "21575.7443"
    },
    {
      "id": 280031,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Markowitz Wayne",
      "reporting_owner_cik": "0001991414",
      "reporting_owner_position": "GM & SVP, Surgical",
      "transaction_date": "2024-05-07",
      "transaction_shares": "3350.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "10648.5547"
    },
    {
      "id": 280034,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-05-07",
      "transaction_shares": "32025.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "77601.4373"
    },
    {
      "id": 280042,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-07",
      "transaction_shares": "11075.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "32549.0000"
    },
    {
      "id": 280047,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-05-07",
      "transaction_shares": "2445.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "17488.1980"
    },
    {
      "id": 323120,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-05-07",
      "transaction_shares": "8725.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "225205.7390"
    },
    {
      "id": 323129,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-05-07",
      "transaction_shares": "6700.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "48368.7184"
    },
    {
      "id": 323139,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-07",
      "transaction_shares": "7125.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "184834.8055"
    },
    {
      "id": 323149,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-07",
      "transaction_shares": "33500.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "80335.9005"
    },
    {
      "id": 323182,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-05-07",
      "transaction_shares": "7000.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "31851.0000"
    },
    {
      "id": 323194,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-05-07",
      "transaction_shares": "4660.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "21575.7443"
    },
    {
      "id": 323195,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Markowitz Wayne",
      "reporting_owner_cik": "0001991414",
      "reporting_owner_position": "GM & SVP, Surgical",
      "transaction_date": "2024-05-07",
      "transaction_shares": "3350.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "10648.5547"
    },
    {
      "id": 323198,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-05-07",
      "transaction_shares": "32025.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "77601.4373"
    },
    {
      "id": 323206,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-07",
      "transaction_shares": "11075.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "32549.0000"
    },
    {
      "id": 323211,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-05-07",
      "transaction_shares": "2445.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "17488.1980"
    },
    {
      "id": 369797,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-05-07",
      "transaction_shares": "8725.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "225205.7390"
    },
    {
      "id": 369806,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-05-07",
      "transaction_shares": "6700.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "48368.7184"
    },
    {
      "id": 369816,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-07",
      "transaction_shares": "7125.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "184834.8055"
    },
    {
      "id": 369826,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-07",
      "transaction_shares": "33500.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "80335.9005"
    },
    {
      "id": 369860,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-05-07",
      "transaction_shares": "7000.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "31851.0000"
    },
    {
      "id": 369873,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-05-07",
      "transaction_shares": "4660.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "21575.7443"
    },
    {
      "id": 369874,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Markowitz Wayne",
      "reporting_owner_cik": "0001991414",
      "reporting_owner_position": "GM & SVP, Surgical",
      "transaction_date": "2024-05-07",
      "transaction_shares": "3350.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "10648.5547"
    },
    {
      "id": 369877,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-05-07",
      "transaction_shares": "32025.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "77601.4373"
    },
    {
      "id": 369885,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-07",
      "transaction_shares": "11075.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "32549.0000"
    },
    {
      "id": 369890,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-05-07",
      "transaction_shares": "2445.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "17488.1980"
    },
    {
      "id": 34264,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-05-03",
      "transaction_shares": "281.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "17206.7443"
    },
    {
      "id": 34269,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-03",
      "transaction_shares": "634.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "18440.0000"
    },
    {
      "id": 34285,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-05-03",
      "transaction_shares": "479.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "43222.4373"
    },
    {
      "id": 34289,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-05-03",
      "transaction_shares": "291.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "22459.0000"
    },
    {
      "id": 34290,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-05-03",
      "transaction_shares": "479.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "39288.7184"
    },
    {
      "id": 34297,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-03",
      "transaction_shares": "527.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "44288.9005"
    },
    {
      "id": 34305,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-05-03",
      "transaction_shares": "106.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "15163.1980"
    },
    {
      "id": 34315,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-03",
      "transaction_shares": "37.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "173811.8055"
    },
    {
      "id": 34319,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-05-03",
      "transaction_shares": "395.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "213346.7390"
    },
    {
      "id": 52430,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-05-03",
      "transaction_shares": "281.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "17206.7443"
    },
    {
      "id": 52435,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-03",
      "transaction_shares": "634.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "18440.0000"
    },
    {
      "id": 52451,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-05-03",
      "transaction_shares": "479.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "43222.4373"
    },
    {
      "id": 52455,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-05-03",
      "transaction_shares": "291.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "22459.0000"
    },
    {
      "id": 52456,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-05-03",
      "transaction_shares": "479.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "39288.7184"
    },
    {
      "id": 52463,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-03",
      "transaction_shares": "527.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "44288.9005"
    },
    {
      "id": 52471,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-05-03",
      "transaction_shares": "106.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "15163.1980"
    },
    {
      "id": 52484,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-03",
      "transaction_shares": "37.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "173811.8055"
    },
    {
      "id": 52488,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-05-03",
      "transaction_shares": "395.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "213346.7390"
    },
    {
      "id": 73087,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-05-03",
      "transaction_shares": "281.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "17206.7443"
    },
    {
      "id": 73092,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-03",
      "transaction_shares": "634.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "18440.0000"
    },
    {
      "id": 73109,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-05-03",
      "transaction_shares": "479.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "43222.4373"
    },
    {
      "id": 73113,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-05-03",
      "transaction_shares": "291.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "22459.0000"
    },
    {
      "id": 73115,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-05-03",
      "transaction_shares": "479.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "39288.7184"
    },
    {
      "id": 73123,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-03",
      "transaction_shares": "527.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "44288.9005"
    },
    {
      "id": 73131,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-05-03",
      "transaction_shares": "106.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "15163.1980"
    },
    {
      "id": 73146,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-03",
      "transaction_shares": "37.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "173811.8055"
    },
    {
      "id": 73150,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-05-03",
      "transaction_shares": "395.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "213346.7390"
    },
    {
      "id": 95869,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-05-03",
      "transaction_shares": "281.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "17206.7443"
    },
    {
      "id": 95874,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-03",
      "transaction_shares": "634.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "18440.0000"
    },
    {
      "id": 95892,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-05-03",
      "transaction_shares": "479.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "43222.4373"
    },
    {
      "id": 95896,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-05-03",
      "transaction_shares": "291.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "22459.0000"
    },
    {
      "id": 95898,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-05-03",
      "transaction_shares": "479.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "39288.7184"
    },
    {
      "id": 95907,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-03",
      "transaction_shares": "527.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "44288.9005"
    },
    {
      "id": 95915,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-05-03",
      "transaction_shares": "106.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "15163.1980"
    },
    {
      "id": 95930,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-03",
      "transaction_shares": "37.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "173811.8055"
    },
    {
      "id": 95934,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-05-03",
      "transaction_shares": "395.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "213346.7390"
    },
    {
      "id": 120778,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-05-03",
      "transaction_shares": "281.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "17206.7443"
    },
    {
      "id": 120784,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-03",
      "transaction_shares": "634.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "18440.0000"
    },
    {
      "id": 120804,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-05-03",
      "transaction_shares": "479.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "43222.4373"
    },
    {
      "id": 120808,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-05-03",
      "transaction_shares": "291.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "22459.0000"
    },
    {
      "id": 120810,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-05-03",
      "transaction_shares": "479.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "39288.7184"
    },
    {
      "id": 120819,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-03",
      "transaction_shares": "527.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "44288.9005"
    },
    {
      "id": 120827,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-05-03",
      "transaction_shares": "106.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "15163.1980"
    },
    {
      "id": 120842,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-03",
      "transaction_shares": "37.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "173811.8055"
    },
    {
      "id": 120846,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-05-03",
      "transaction_shares": "395.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "213346.7390"
    },
    {
      "id": 147688,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-05-03",
      "transaction_shares": "281.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "17206.7443"
    },
    {
      "id": 147694,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-03",
      "transaction_shares": "634.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "18440.0000"
    },
    {
      "id": 147715,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-05-03",
      "transaction_shares": "479.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "43222.4373"
    },
    {
      "id": 147719,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-05-03",
      "transaction_shares": "291.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "22459.0000"
    },
    {
      "id": 147721,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-05-03",
      "transaction_shares": "479.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "39288.7184"
    },
    {
      "id": 147730,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-03",
      "transaction_shares": "527.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "44288.9005"
    },
    {
      "id": 147738,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-05-03",
      "transaction_shares": "106.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "15163.1980"
    },
    {
      "id": 147753,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-03",
      "transaction_shares": "37.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "173811.8055"
    },
    {
      "id": 147757,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-05-03",
      "transaction_shares": "395.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "213346.7390"
    },
    {
      "id": 176689,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-05-03",
      "transaction_shares": "281.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "17206.7443"
    },
    {
      "id": 176695,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-03",
      "transaction_shares": "634.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "18440.0000"
    },
    {
      "id": 176716,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-05-03",
      "transaction_shares": "479.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "43222.4373"
    },
    {
      "id": 176720,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-05-03",
      "transaction_shares": "291.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "22459.0000"
    },
    {
      "id": 176722,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-05-03",
      "transaction_shares": "479.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "39288.7184"
    },
    {
      "id": 176731,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-03",
      "transaction_shares": "527.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "44288.9005"
    },
    {
      "id": 176739,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-05-03",
      "transaction_shares": "106.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "15163.1980"
    },
    {
      "id": 176754,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-03",
      "transaction_shares": "37.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "173811.8055"
    },
    {
      "id": 176758,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-05-03",
      "transaction_shares": "395.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "213346.7390"
    },
    {
      "id": 208174,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-05-03",
      "transaction_shares": "281.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "17206.7443"
    },
    {
      "id": 208180,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-03",
      "transaction_shares": "634.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "18440.0000"
    },
    {
      "id": 208203,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-05-03",
      "transaction_shares": "479.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "43222.4373"
    },
    {
      "id": 208207,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-05-03",
      "transaction_shares": "291.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "22459.0000"
    },
    {
      "id": 208209,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-05-03",
      "transaction_shares": "479.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "39288.7184"
    },
    {
      "id": 208218,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-03",
      "transaction_shares": "527.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "44288.9005"
    },
    {
      "id": 208227,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-05-03",
      "transaction_shares": "106.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "15163.1980"
    },
    {
      "id": 208243,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-03",
      "transaction_shares": "37.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "173811.8055"
    },
    {
      "id": 208248,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-05-03",
      "transaction_shares": "395.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "213346.7390"
    },
    {
      "id": 242179,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-05-03",
      "transaction_shares": "281.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "17206.7443"
    },
    {
      "id": 242185,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-03",
      "transaction_shares": "634.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "18440.0000"
    },
    {
      "id": 242208,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-05-03",
      "transaction_shares": "479.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "43222.4373"
    },
    {
      "id": 242212,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-05-03",
      "transaction_shares": "291.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "22459.0000"
    },
    {
      "id": 242214,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-05-03",
      "transaction_shares": "479.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "39288.7184"
    },
    {
      "id": 242223,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-03",
      "transaction_shares": "527.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "44288.9005"
    },
    {
      "id": 242233,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-05-03",
      "transaction_shares": "106.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "15163.1980"
    },
    {
      "id": 242249,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-03",
      "transaction_shares": "37.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "173811.8055"
    },
    {
      "id": 242254,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-05-03",
      "transaction_shares": "395.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "213346.7390"
    },
    {
      "id": 279958,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-05-03",
      "transaction_shares": "281.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "17206.7443"
    },
    {
      "id": 279966,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-03",
      "transaction_shares": "634.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "18440.0000"
    },
    {
      "id": 279992,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-05-03",
      "transaction_shares": "479.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "43222.4373"
    },
    {
      "id": 279997,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-05-03",
      "transaction_shares": "291.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "22459.0000"
    },
    {
      "id": 279999,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-05-03",
      "transaction_shares": "479.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "39288.7184"
    },
    {
      "id": 280010,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-03",
      "transaction_shares": "527.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "44288.9005"
    },
    {
      "id": 280021,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-05-03",
      "transaction_shares": "106.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "15163.1980"
    },
    {
      "id": 280038,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-03",
      "transaction_shares": "37.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "173811.8055"
    },
    {
      "id": 280043,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-05-03",
      "transaction_shares": "395.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "213346.7390"
    },
    {
      "id": 323118,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-05-03",
      "transaction_shares": "281.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "17206.7443"
    },
    {
      "id": 323127,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-03",
      "transaction_shares": "634.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "18440.0000"
    },
    {
      "id": 323153,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-05-03",
      "transaction_shares": "479.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "43222.4373"
    },
    {
      "id": 323158,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-05-03",
      "transaction_shares": "291.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "22459.0000"
    },
    {
      "id": 323160,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-05-03",
      "transaction_shares": "479.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "39288.7184"
    },
    {
      "id": 323171,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-03",
      "transaction_shares": "527.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "44288.9005"
    },
    {
      "id": 323183,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-05-03",
      "transaction_shares": "106.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "15163.1980"
    },
    {
      "id": 323202,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-03",
      "transaction_shares": "37.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "173811.8055"
    },
    {
      "id": 323207,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-05-03",
      "transaction_shares": "395.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "213346.7390"
    },
    {
      "id": 369795,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-05-03",
      "transaction_shares": "281.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "17206.7443"
    },
    {
      "id": 369804,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-03",
      "transaction_shares": "634.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "18440.0000"
    },
    {
      "id": 369830,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-05-03",
      "transaction_shares": "479.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "43222.4373"
    },
    {
      "id": 369836,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-05-03",
      "transaction_shares": "291.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "22459.0000"
    },
    {
      "id": 369838,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-05-03",
      "transaction_shares": "479.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "39288.7184"
    },
    {
      "id": 369849,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-03",
      "transaction_shares": "527.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "44288.9005"
    },
    {
      "id": 369861,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-05-03",
      "transaction_shares": "106.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "15163.1980"
    },
    {
      "id": 369881,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-03",
      "transaction_shares": "37.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "173811.8055"
    },
    {
      "id": 369886,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-05-03",
      "transaction_shares": "395.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "213346.7390"
    },
    {
      "id": 34274,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-02",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 52440,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-02",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 73097,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-02",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 95879,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-02",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 120790,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-02",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 147700,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-02",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 176701,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-02",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 208187,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-02",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 242192,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-02",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 279974,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-02",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 323135,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-02",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 369812,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-02",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 34322,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-01",
      "transaction_shares": "14400.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "188248.8055"
    },
    {
      "id": 52491,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-01",
      "transaction_shares": "14400.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "188248.8055"
    },
    {
      "id": 73153,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-01",
      "transaction_shares": "14400.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "188248.8055"
    },
    {
      "id": 95937,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-01",
      "transaction_shares": "14400.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "188248.8055"
    },
    {
      "id": 120849,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-01",
      "transaction_shares": "14400.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "188248.8055"
    },
    {
      "id": 147760,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-01",
      "transaction_shares": "14400.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "188248.8055"
    },
    {
      "id": 176762,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-01",
      "transaction_shares": "14400.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "188248.8055"
    },
    {
      "id": 208252,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-01",
      "transaction_shares": "14400.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "188248.8055"
    },
    {
      "id": 242259,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-01",
      "transaction_shares": "14400.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "188248.8055"
    },
    {
      "id": 280048,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-01",
      "transaction_shares": "14400.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "188248.8055"
    },
    {
      "id": 323212,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-01",
      "transaction_shares": "14400.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "188248.8055"
    },
    {
      "id": 369891,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-01",
      "transaction_shares": "14400.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "188248.8055"
    },
    {
      "id": 34288,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-04-30",
      "transaction_shares": "7250.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26324.0000"
    },
    {
      "id": 52454,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-04-30",
      "transaction_shares": "7250.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26324.0000"
    },
    {
      "id": 73112,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-04-30",
      "transaction_shares": "7250.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26324.0000"
    },
    {
      "id": 95895,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-04-30",
      "transaction_shares": "7250.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26324.0000"
    },
    {
      "id": 120807,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-04-30",
      "transaction_shares": "7250.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26324.0000"
    },
    {
      "id": 147718,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-04-30",
      "transaction_shares": "7250.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26324.0000"
    },
    {
      "id": 176719,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-04-30",
      "transaction_shares": "7250.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26324.0000"
    },
    {
      "id": 208206,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-04-30",
      "transaction_shares": "7250.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26324.0000"
    },
    {
      "id": 242211,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-04-30",
      "transaction_shares": "7250.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26324.0000"
    },
    {
      "id": 279996,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-04-30",
      "transaction_shares": "7250.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26324.0000"
    },
    {
      "id": 323157,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-04-30",
      "transaction_shares": "7250.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26324.0000"
    },
    {
      "id": 369835,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-04-30",
      "transaction_shares": "7250.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26324.0000"
    },
    {
      "id": 19864,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-04-09",
      "transaction_shares": "857.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "18344.7443"
    },
    {
      "id": 34309,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-04-09",
      "transaction_shares": "857.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "18344.7443"
    },
    {
      "id": 52475,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-04-09",
      "transaction_shares": "857.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "18344.7443"
    },
    {
      "id": 73136,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-04-09",
      "transaction_shares": "857.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "18344.7443"
    },
    {
      "id": 95920,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-04-09",
      "transaction_shares": "857.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "18344.7443"
    },
    {
      "id": 120832,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-04-09",
      "transaction_shares": "857.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "18344.7443"
    },
    {
      "id": 147743,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-04-09",
      "transaction_shares": "857.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "18344.7443"
    },
    {
      "id": 176744,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-04-09",
      "transaction_shares": "857.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "18344.7443"
    },
    {
      "id": 208233,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-04-09",
      "transaction_shares": "857.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "18344.7443"
    },
    {
      "id": 242239,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-04-09",
      "transaction_shares": "857.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "18344.7443"
    },
    {
      "id": 280027,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-04-09",
      "transaction_shares": "857.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "18344.7443"
    },
    {
      "id": 323190,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-04-09",
      "transaction_shares": "857.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "18344.7443"
    },
    {
      "id": 369869,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-04-09",
      "transaction_shares": "857.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "18344.7443"
    },
    {
      "id": 19848,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA",
      "transaction_date": "2024-04-08",
      "transaction_shares": "14400.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "188248.8055"
    },
    {
      "id": 19855,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-04-08",
      "transaction_shares": "12500.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "52267.7184"
    },
    {
      "id": 34276,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA",
      "transaction_date": "2024-04-08",
      "transaction_shares": "14400.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "188248.8055"
    },
    {
      "id": 34292,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-04-08",
      "transaction_shares": "12500.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "52267.7184"
    },
    {
      "id": 52442,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA",
      "transaction_date": "2024-04-08",
      "transaction_shares": "14400.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "188248.8055"
    },
    {
      "id": 52458,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-04-08",
      "transaction_shares": "12500.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "52267.7184"
    },
    {
      "id": 73099,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA",
      "transaction_date": "2024-04-08",
      "transaction_shares": "14400.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "188248.8055"
    },
    {
      "id": 73117,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-04-08",
      "transaction_shares": "12500.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "52267.7184"
    },
    {
      "id": 95881,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA",
      "transaction_date": "2024-04-08",
      "transaction_shares": "14400.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "188248.8055"
    },
    {
      "id": 95900,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-04-08",
      "transaction_shares": "12500.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "52267.7184"
    },
    {
      "id": 120792,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA",
      "transaction_date": "2024-04-08",
      "transaction_shares": "14400.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "188248.8055"
    },
    {
      "id": 120812,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-04-08",
      "transaction_shares": "12500.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "52267.7184"
    },
    {
      "id": 147702,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA",
      "transaction_date": "2024-04-08",
      "transaction_shares": "14400.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "188248.8055"
    },
    {
      "id": 147723,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-04-08",
      "transaction_shares": "12500.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "52267.7184"
    },
    {
      "id": 176703,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA",
      "transaction_date": "2024-04-08",
      "transaction_shares": "14400.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "188248.8055"
    },
    {
      "id": 176724,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-04-08",
      "transaction_shares": "12500.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "52267.7184"
    },
    {
      "id": 208189,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA",
      "transaction_date": "2024-04-08",
      "transaction_shares": "14400.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "188248.8055"
    },
    {
      "id": 208211,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-04-08",
      "transaction_shares": "12500.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "52267.7184"
    },
    {
      "id": 242194,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA",
      "transaction_date": "2024-04-08",
      "transaction_shares": "14400.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "188248.8055"
    },
    {
      "id": 242216,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-04-08",
      "transaction_shares": "12500.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "52267.7184"
    },
    {
      "id": 279976,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA",
      "transaction_date": "2024-04-08",
      "transaction_shares": "14400.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "188248.8055"
    },
    {
      "id": 280001,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-04-08",
      "transaction_shares": "12500.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "52267.7184"
    },
    {
      "id": 323137,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA",
      "transaction_date": "2024-04-08",
      "transaction_shares": "14400.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "188248.8055"
    },
    {
      "id": 323162,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-04-08",
      "transaction_shares": "12500.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "52267.7184"
    },
    {
      "id": 369814,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA",
      "transaction_date": "2024-04-08",
      "transaction_shares": "14400.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "188248.8055"
    },
    {
      "id": 369840,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-04-08",
      "transaction_shares": "12500.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "52267.7184"
    },
    {
      "id": 19845,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-04",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 34270,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-04",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 52436,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-04",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 73093,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-04",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 95875,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-04",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 120785,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-04",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 147695,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-04",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 176696,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-04",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 208181,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-04",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 242186,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-04",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 279967,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-04",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 323128,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-04",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 369805,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-04",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 19863,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26329.0000"
    },
    {
      "id": 34308,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26329.0000"
    },
    {
      "id": 52474,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26329.0000"
    },
    {
      "id": 73135,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26329.0000"
    },
    {
      "id": 95919,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26329.0000"
    },
    {
      "id": 120831,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26329.0000"
    },
    {
      "id": 147742,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26329.0000"
    },
    {
      "id": 176743,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26329.0000"
    },
    {
      "id": 208231,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26329.0000"
    },
    {
      "id": 242237,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26329.0000"
    },
    {
      "id": 280025,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26329.0000"
    },
    {
      "id": 323187,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26329.0000"
    },
    {
      "id": 369866,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26329.0000"
    },
    {
      "id": 8486,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-03-13",
      "transaction_shares": "14500.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "54002.6931"
    },
    {
      "id": 19866,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-03-13",
      "transaction_shares": "14500.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "54002.6931"
    },
    {
      "id": 34323,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-03-13",
      "transaction_shares": "14500.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "54002.6931"
    },
    {
      "id": 52492,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-03-13",
      "transaction_shares": "14500.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "54002.6931"
    },
    {
      "id": 73155,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-03-13",
      "transaction_shares": "14500.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "54002.6931"
    },
    {
      "id": 95939,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-03-13",
      "transaction_shares": "14500.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "54002.6931"
    },
    {
      "id": 120851,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-03-13",
      "transaction_shares": "14500.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "54002.6931"
    },
    {
      "id": 147762,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-03-13",
      "transaction_shares": "14500.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "54002.6931"
    },
    {
      "id": 176764,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-03-13",
      "transaction_shares": "14500.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "54002.6931"
    },
    {
      "id": 208254,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-03-13",
      "transaction_shares": "14500.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "54002.6931"
    },
    {
      "id": 242261,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-03-13",
      "transaction_shares": "14500.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "54002.6931"
    },
    {
      "id": 280050,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-03-13",
      "transaction_shares": "14500.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "54002.6931"
    },
    {
      "id": 323214,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-03-13",
      "transaction_shares": "14500.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "54002.6931"
    },
    {
      "id": 369893,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-03-13",
      "transaction_shares": "14500.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "54002.6931"
    },
    {
      "id": 8480,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-03-11",
      "transaction_shares": "14400.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "187983.7785"
    },
    {
      "id": 19858,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-03-11",
      "transaction_shares": "14400.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "187983.7785"
    },
    {
      "id": 34300,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-03-11",
      "transaction_shares": "14400.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "187983.7785"
    },
    {
      "id": 52466,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-03-11",
      "transaction_shares": "14400.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "187983.7785"
    },
    {
      "id": 73126,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-03-11",
      "transaction_shares": "14400.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "187983.7785"
    },
    {
      "id": 95910,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-03-11",
      "transaction_shares": "14400.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "187983.7785"
    },
    {
      "id": 120822,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-03-11",
      "transaction_shares": "14400.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "187983.7785"
    },
    {
      "id": 147733,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-03-11",
      "transaction_shares": "14400.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "187983.7785"
    },
    {
      "id": 176734,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-03-11",
      "transaction_shares": "14400.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "187983.7785"
    },
    {
      "id": 208222,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-03-11",
      "transaction_shares": "14400.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "187983.7785"
    },
    {
      "id": 242228,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-03-11",
      "transaction_shares": "14400.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "187983.7785"
    },
    {
      "id": 280015,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-03-11",
      "transaction_shares": "14400.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "187983.7785"
    },
    {
      "id": 323176,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-03-11",
      "transaction_shares": "14400.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "187983.7785"
    },
    {
      "id": 369854,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-03-11",
      "transaction_shares": "14400.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "187983.7785"
    },
    {
      "id": 8482,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-03-07",
      "transaction_shares": "1715.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "18928.2105"
    },
    {
      "id": 19860,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-03-07",
      "transaction_shares": "1715.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "18928.2105"
    },
    {
      "id": 34302,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-03-07",
      "transaction_shares": "1715.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "18928.2105"
    },
    {
      "id": 52468,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-03-07",
      "transaction_shares": "1715.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "18928.2105"
    },
    {
      "id": 73128,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-03-07",
      "transaction_shares": "1715.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "18928.2105"
    },
    {
      "id": 95912,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-03-07",
      "transaction_shares": "1715.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "18928.2105"
    },
    {
      "id": 120824,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-03-07",
      "transaction_shares": "1715.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "18928.2105"
    },
    {
      "id": 147735,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-03-07",
      "transaction_shares": "1715.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "18928.2105"
    },
    {
      "id": 176736,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-03-07",
      "transaction_shares": "1715.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "18928.2105"
    },
    {
      "id": 208224,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-03-07",
      "transaction_shares": "1715.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "18928.2105"
    },
    {
      "id": 242230,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-03-07",
      "transaction_shares": "1715.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "18928.2105"
    },
    {
      "id": 280018,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-03-07",
      "transaction_shares": "1715.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "18928.2105"
    },
    {
      "id": 323180,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-03-07",
      "transaction_shares": "1715.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "18928.2105"
    },
    {
      "id": 369858,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-03-07",
      "transaction_shares": "1715.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "18928.2105"
    },
    {
      "id": 8469,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-03-04",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 19844,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-03-04",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 34265,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-03-04",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 52431,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-03-04",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 73088,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-03-04",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 95870,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-03-04",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 120779,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-03-04",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 147689,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-03-04",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 176690,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-03-04",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 208175,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-03-04",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 242180,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-03-04",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 279959,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-03-04",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 323119,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-03-04",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 369796,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-03-04",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 8472,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-29",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26329.0000"
    },
    {
      "id": 19849,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-29",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26329.0000"
    },
    {
      "id": 34278,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-29",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26329.0000"
    },
    {
      "id": 52444,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-29",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26329.0000"
    },
    {
      "id": 73102,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-29",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26329.0000"
    },
    {
      "id": 95884,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-29",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26329.0000"
    },
    {
      "id": 120795,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-29",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26329.0000"
    },
    {
      "id": 147705,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-29",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26329.0000"
    },
    {
      "id": 176706,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-29",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26329.0000"
    },
    {
      "id": 208192,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-29",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26329.0000"
    },
    {
      "id": 242197,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-29",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26329.0000"
    },
    {
      "id": 279979,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-29",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26329.0000"
    },
    {
      "id": 323140,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-29",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26329.0000"
    },
    {
      "id": 369817,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-29",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26329.0000"
    },
    {
      "id": 8479,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "GALLAHUE KIERAN",
      "reporting_owner_cik": "0001308428",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-23",
      "transaction_shares": "7056.0000",
      "transaction_price": "36.8633",
      "transaction_type": "M",
      "shares_after_transaction": "10757.0000"
    },
    {
      "id": 19857,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "GALLAHUE KIERAN",
      "reporting_owner_cik": "0001308428",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-23",
      "transaction_shares": "7056.0000",
      "transaction_price": "36.8633",
      "transaction_type": "M",
      "shares_after_transaction": "10757.0000"
    },
    {
      "id": 34296,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "GALLAHUE KIERAN",
      "reporting_owner_cik": "0001308428",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-23",
      "transaction_shares": "7056.0000",
      "transaction_price": "36.8633",
      "transaction_type": "M",
      "shares_after_transaction": "10757.0000"
    },
    {
      "id": 52462,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "GALLAHUE KIERAN",
      "reporting_owner_cik": "0001308428",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-23",
      "transaction_shares": "7056.0000",
      "transaction_price": "36.8633",
      "transaction_type": "M",
      "shares_after_transaction": "10757.0000"
    },
    {
      "id": 73122,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "GALLAHUE KIERAN",
      "reporting_owner_cik": "0001308428",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-23",
      "transaction_shares": "7056.0000",
      "transaction_price": "36.8633",
      "transaction_type": "M",
      "shares_after_transaction": "10757.0000"
    },
    {
      "id": 95906,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "GALLAHUE KIERAN",
      "reporting_owner_cik": "0001308428",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-23",
      "transaction_shares": "7056.0000",
      "transaction_price": "36.8633",
      "transaction_type": "M",
      "shares_after_transaction": "10757.0000"
    },
    {
      "id": 120818,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "GALLAHUE KIERAN",
      "reporting_owner_cik": "0001308428",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-23",
      "transaction_shares": "7056.0000",
      "transaction_price": "36.8633",
      "transaction_type": "M",
      "shares_after_transaction": "10757.0000"
    },
    {
      "id": 147729,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "GALLAHUE KIERAN",
      "reporting_owner_cik": "0001308428",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-23",
      "transaction_shares": "7056.0000",
      "transaction_price": "36.8633",
      "transaction_type": "M",
      "shares_after_transaction": "10757.0000"
    },
    {
      "id": 176730,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "GALLAHUE KIERAN",
      "reporting_owner_cik": "0001308428",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-23",
      "transaction_shares": "7056.0000",
      "transaction_price": "36.8633",
      "transaction_type": "M",
      "shares_after_transaction": "10757.0000"
    },
    {
      "id": 208217,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "GALLAHUE KIERAN",
      "reporting_owner_cik": "0001308428",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-23",
      "transaction_shares": "7056.0000",
      "transaction_price": "36.8633",
      "transaction_type": "M",
      "shares_after_transaction": "10757.0000"
    },
    {
      "id": 242222,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "GALLAHUE KIERAN",
      "reporting_owner_cik": "0001308428",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-23",
      "transaction_shares": "7056.0000",
      "transaction_price": "36.8633",
      "transaction_type": "M",
      "shares_after_transaction": "10757.0000"
    },
    {
      "id": 280009,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "GALLAHUE KIERAN",
      "reporting_owner_cik": "0001308428",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-23",
      "transaction_shares": "7056.0000",
      "transaction_price": "36.8633",
      "transaction_type": "M",
      "shares_after_transaction": "10757.0000"
    },
    {
      "id": 323170,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "GALLAHUE KIERAN",
      "reporting_owner_cik": "0001308428",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-23",
      "transaction_shares": "7056.0000",
      "transaction_price": "36.8633",
      "transaction_type": "M",
      "shares_after_transaction": "10757.0000"
    },
    {
      "id": 369848,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "GALLAHUE KIERAN",
      "reporting_owner_cik": "0001308428",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-23",
      "transaction_shares": "7056.0000",
      "transaction_price": "36.8633",
      "transaction_type": "M",
      "shares_after_transaction": "10757.0000"
    },
    {
      "id": 8475,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-02-22",
      "transaction_shares": "8560.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "43373.5710"
    },
    {
      "id": 8481,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-02-22",
      "transaction_shares": "1998.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "15085.1838"
    },
    {
      "id": 19852,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-02-22",
      "transaction_shares": "8560.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "43373.5710"
    },
    {
      "id": 19859,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-02-22",
      "transaction_shares": "1998.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "15085.1838"
    },
    {
      "id": 34281,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-02-22",
      "transaction_shares": "8560.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "43373.5710"
    },
    {
      "id": 34301,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-02-22",
      "transaction_shares": "1998.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "15085.1838"
    },
    {
      "id": 52447,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-02-22",
      "transaction_shares": "8560.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "43373.5710"
    },
    {
      "id": 52467,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-02-22",
      "transaction_shares": "1998.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "15085.1838"
    },
    {
      "id": 73105,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-02-22",
      "transaction_shares": "8560.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "43373.5710"
    },
    {
      "id": 73127,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-02-22",
      "transaction_shares": "1998.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "15085.1838"
    },
    {
      "id": 95888,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-02-22",
      "transaction_shares": "8560.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "43373.5710"
    },
    {
      "id": 95911,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-02-22",
      "transaction_shares": "1998.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "15085.1838"
    },
    {
      "id": 120800,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-02-22",
      "transaction_shares": "8560.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "43373.5710"
    },
    {
      "id": 120823,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-02-22",
      "transaction_shares": "1998.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "15085.1838"
    },
    {
      "id": 147711,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-02-22",
      "transaction_shares": "8560.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "43373.5710"
    },
    {
      "id": 147734,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-02-22",
      "transaction_shares": "1998.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "15085.1838"
    },
    {
      "id": 176712,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-02-22",
      "transaction_shares": "8560.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "43373.5710"
    },
    {
      "id": 176735,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-02-22",
      "transaction_shares": "1998.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "15085.1838"
    },
    {
      "id": 208199,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-02-22",
      "transaction_shares": "8560.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "43373.5710"
    },
    {
      "id": 208223,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-02-22",
      "transaction_shares": "1998.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "15085.1838"
    },
    {
      "id": 242204,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-02-22",
      "transaction_shares": "8560.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "43373.5710"
    },
    {
      "id": 242229,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-02-22",
      "transaction_shares": "1998.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "15085.1838"
    },
    {
      "id": 279987,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-02-22",
      "transaction_shares": "8560.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "43373.5710"
    },
    {
      "id": 280017,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-02-22",
      "transaction_shares": "1998.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "15085.1838"
    },
    {
      "id": 323148,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-02-22",
      "transaction_shares": "8560.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "43373.5710"
    },
    {
      "id": 323178,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-02-22",
      "transaction_shares": "1998.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "15085.1838"
    },
    {
      "id": 369825,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-02-22",
      "transaction_shares": "8560.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "43373.5710"
    },
    {
      "id": 369856,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-02-22",
      "transaction_shares": "1998.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "15085.1838"
    },
    {
      "id": 1587,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-02-21",
      "transaction_shares": "7000.0000",
      "transaction_price": "59.2567",
      "transaction_type": "M",
      "shares_after_transaction": "30950.0000"
    },
    {
      "id": 8471,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-02-21",
      "transaction_shares": "7000.0000",
      "transaction_price": "59.2567",
      "transaction_type": "M",
      "shares_after_transaction": "30950.0000"
    },
    {
      "id": 19847,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-02-21",
      "transaction_shares": "7000.0000",
      "transaction_price": "59.2567",
      "transaction_type": "M",
      "shares_after_transaction": "30950.0000"
    },
    {
      "id": 34275,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-02-21",
      "transaction_shares": "7000.0000",
      "transaction_price": "59.2567",
      "transaction_type": "M",
      "shares_after_transaction": "30950.0000"
    },
    {
      "id": 52441,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-02-21",
      "transaction_shares": "7000.0000",
      "transaction_price": "59.2567",
      "transaction_type": "M",
      "shares_after_transaction": "30950.0000"
    },
    {
      "id": 73098,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-02-21",
      "transaction_shares": "7000.0000",
      "transaction_price": "59.2567",
      "transaction_type": "M",
      "shares_after_transaction": "30950.0000"
    },
    {
      "id": 95880,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-02-21",
      "transaction_shares": "7000.0000",
      "transaction_price": "59.2567",
      "transaction_type": "M",
      "shares_after_transaction": "30950.0000"
    },
    {
      "id": 120791,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-02-21",
      "transaction_shares": "7000.0000",
      "transaction_price": "59.2567",
      "transaction_type": "M",
      "shares_after_transaction": "30950.0000"
    },
    {
      "id": 147701,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-02-21",
      "transaction_shares": "7000.0000",
      "transaction_price": "59.2567",
      "transaction_type": "M",
      "shares_after_transaction": "30950.0000"
    },
    {
      "id": 176702,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-02-21",
      "transaction_shares": "7000.0000",
      "transaction_price": "59.2567",
      "transaction_type": "M",
      "shares_after_transaction": "30950.0000"
    },
    {
      "id": 208188,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-02-21",
      "transaction_shares": "7000.0000",
      "transaction_price": "59.2567",
      "transaction_type": "M",
      "shares_after_transaction": "30950.0000"
    },
    {
      "id": 242193,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-02-21",
      "transaction_shares": "7000.0000",
      "transaction_price": "59.2567",
      "transaction_type": "M",
      "shares_after_transaction": "30950.0000"
    },
    {
      "id": 279975,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-02-21",
      "transaction_shares": "7000.0000",
      "transaction_price": "59.2567",
      "transaction_type": "M",
      "shares_after_transaction": "30950.0000"
    },
    {
      "id": 323136,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-02-21",
      "transaction_shares": "7000.0000",
      "transaction_price": "59.2567",
      "transaction_type": "M",
      "shares_after_transaction": "30950.0000"
    },
    {
      "id": 369813,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-02-21",
      "transaction_shares": "7000.0000",
      "transaction_price": "59.2567",
      "transaction_type": "M",
      "shares_after_transaction": "30950.0000"
    },
    {
      "id": 1591,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-02-16",
      "transaction_shares": "207.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "17551.2105"
    },
    {
      "id": 1592,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-16",
      "transaction_shares": "174.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "19074.0000"
    },
    {
      "id": 1593,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-02-16",
      "transaction_shares": "317.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "213476.7137"
    },
    {
      "id": 8477,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-02-16",
      "transaction_shares": "207.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "17551.2105"
    },
    {
      "id": 8478,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-16",
      "transaction_shares": "174.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "19074.0000"
    },
    {
      "id": 8483,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-02-16",
      "transaction_shares": "317.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "213476.7137"
    },
    {
      "id": 19854,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-02-16",
      "transaction_shares": "207.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "17551.2105"
    },
    {
      "id": 19856,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-16",
      "transaction_shares": "174.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "19074.0000"
    },
    {
      "id": 19861,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-02-16",
      "transaction_shares": "317.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "213476.7137"
    },
    {
      "id": 34287,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-02-16",
      "transaction_shares": "207.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "17551.2105"
    },
    {
      "id": 34293,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-16",
      "transaction_shares": "174.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "19074.0000"
    },
    {
      "id": 34303,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-02-16",
      "transaction_shares": "317.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "213476.7137"
    },
    {
      "id": 52453,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-02-16",
      "transaction_shares": "207.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "17551.2105"
    },
    {
      "id": 52459,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-16",
      "transaction_shares": "174.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "19074.0000"
    },
    {
      "id": 52469,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-02-16",
      "transaction_shares": "317.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "213476.7137"
    },
    {
      "id": 73111,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-02-16",
      "transaction_shares": "207.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "17551.2105"
    },
    {
      "id": 73118,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-16",
      "transaction_shares": "174.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "19074.0000"
    },
    {
      "id": 73129,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-02-16",
      "transaction_shares": "317.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "213476.7137"
    },
    {
      "id": 95894,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-02-16",
      "transaction_shares": "207.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "17551.2105"
    },
    {
      "id": 95901,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-16",
      "transaction_shares": "174.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "19074.0000"
    },
    {
      "id": 95913,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-02-16",
      "transaction_shares": "317.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "213476.7137"
    },
    {
      "id": 120806,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-02-16",
      "transaction_shares": "207.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "17551.2105"
    },
    {
      "id": 120813,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-16",
      "transaction_shares": "174.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "19074.0000"
    },
    {
      "id": 120825,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-02-16",
      "transaction_shares": "317.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "213476.7137"
    },
    {
      "id": 147717,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-02-16",
      "transaction_shares": "207.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "17551.2105"
    },
    {
      "id": 147724,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-16",
      "transaction_shares": "174.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "19074.0000"
    },
    {
      "id": 147736,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-02-16",
      "transaction_shares": "317.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "213476.7137"
    },
    {
      "id": 176718,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-02-16",
      "transaction_shares": "207.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "17551.2105"
    },
    {
      "id": 176725,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-16",
      "transaction_shares": "174.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "19074.0000"
    },
    {
      "id": 176737,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-02-16",
      "transaction_shares": "317.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "213476.7137"
    },
    {
      "id": 208205,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-02-16",
      "transaction_shares": "207.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "17551.2105"
    },
    {
      "id": 208212,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-16",
      "transaction_shares": "174.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "19074.0000"
    },
    {
      "id": 208225,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-02-16",
      "transaction_shares": "317.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "213476.7137"
    },
    {
      "id": 242210,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-02-16",
      "transaction_shares": "207.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "17551.2105"
    },
    {
      "id": 242217,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-16",
      "transaction_shares": "174.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "19074.0000"
    },
    {
      "id": 242231,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-02-16",
      "transaction_shares": "317.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "213476.7137"
    },
    {
      "id": 279995,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-02-16",
      "transaction_shares": "207.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "17551.2105"
    },
    {
      "id": 280002,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-16",
      "transaction_shares": "174.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "19074.0000"
    },
    {
      "id": 280019,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-02-16",
      "transaction_shares": "317.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "213476.7137"
    },
    {
      "id": 323156,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-02-16",
      "transaction_shares": "207.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "17551.2105"
    },
    {
      "id": 323163,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-16",
      "transaction_shares": "174.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "19074.0000"
    },
    {
      "id": 323181,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-02-16",
      "transaction_shares": "317.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "213476.7137"
    },
    {
      "id": 369834,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-02-16",
      "transaction_shares": "207.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "17551.2105"
    },
    {
      "id": 369841,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-16",
      "transaction_shares": "174.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "19074.0000"
    },
    {
      "id": 369859,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-02-16",
      "transaction_shares": "317.0000",
      "transaction_price": "86.0400",
      "transaction_type": "F",
      "shares_after_transaction": "213476.7137"
    },
    {
      "id": 1589,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-02-13",
      "transaction_shares": "11000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "50502.6931"
    },
    {
      "id": 1590,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-02-13",
      "transaction_shares": "20000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "54813.5710"
    },
    {
      "id": 8474,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-02-13",
      "transaction_shares": "11000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "50502.6931"
    },
    {
      "id": 8476,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-02-13",
      "transaction_shares": "20000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "54813.5710"
    },
    {
      "id": 19851,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-02-13",
      "transaction_shares": "11000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "50502.6931"
    },
    {
      "id": 19853,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-02-13",
      "transaction_shares": "20000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "54813.5710"
    },
    {
      "id": 34280,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-02-13",
      "transaction_shares": "11000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "50502.6931"
    },
    {
      "id": 34283,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-02-13",
      "transaction_shares": "20000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "54813.5710"
    },
    {
      "id": 52446,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-02-13",
      "transaction_shares": "11000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "50502.6931"
    },
    {
      "id": 52449,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-02-13",
      "transaction_shares": "20000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "54813.5710"
    },
    {
      "id": 73104,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-02-13",
      "transaction_shares": "11000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "50502.6931"
    },
    {
      "id": 73107,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-02-13",
      "transaction_shares": "20000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "54813.5710"
    },
    {
      "id": 95886,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-02-13",
      "transaction_shares": "11000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "50502.6931"
    },
    {
      "id": 95890,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-02-13",
      "transaction_shares": "20000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "54813.5710"
    },
    {
      "id": 120798,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-02-13",
      "transaction_shares": "11000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "50502.6931"
    },
    {
      "id": 120802,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-02-13",
      "transaction_shares": "20000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "54813.5710"
    },
    {
      "id": 147709,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-02-13",
      "transaction_shares": "11000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "50502.6931"
    },
    {
      "id": 147713,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-02-13",
      "transaction_shares": "20000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "54813.5710"
    },
    {
      "id": 176710,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-02-13",
      "transaction_shares": "11000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "50502.6931"
    },
    {
      "id": 176714,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-02-13",
      "transaction_shares": "20000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "54813.5710"
    },
    {
      "id": 208196,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-02-13",
      "transaction_shares": "11000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "50502.6931"
    },
    {
      "id": 208201,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-02-13",
      "transaction_shares": "20000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "54813.5710"
    },
    {
      "id": 242201,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-02-13",
      "transaction_shares": "11000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "50502.6931"
    },
    {
      "id": 242206,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-02-13",
      "transaction_shares": "20000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "54813.5710"
    },
    {
      "id": 279984,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-02-13",
      "transaction_shares": "11000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "50502.6931"
    },
    {
      "id": 279990,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-02-13",
      "transaction_shares": "20000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "54813.5710"
    },
    {
      "id": 323145,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-02-13",
      "transaction_shares": "11000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "50502.6931"
    },
    {
      "id": 323151,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-02-13",
      "transaction_shares": "20000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "54813.5710"
    },
    {
      "id": 369822,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-02-13",
      "transaction_shares": "11000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "50502.6931"
    },
    {
      "id": 369828,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-02-13",
      "transaction_shares": "20000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "54813.5710"
    },
    {
      "id": 1594,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-02-12",
      "transaction_shares": "12210.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "25297.1838"
    },
    {
      "id": 8484,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-02-12",
      "transaction_shares": "12210.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "25297.1838"
    },
    {
      "id": 19862,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-02-12",
      "transaction_shares": "12210.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "25297.1838"
    },
    {
      "id": 34307,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-02-12",
      "transaction_shares": "12210.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "25297.1838"
    },
    {
      "id": 52473,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-02-12",
      "transaction_shares": "12210.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "25297.1838"
    },
    {
      "id": 73134,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-02-12",
      "transaction_shares": "12210.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "25297.1838"
    },
    {
      "id": 95918,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-02-12",
      "transaction_shares": "12210.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "25297.1838"
    },
    {
      "id": 120830,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-02-12",
      "transaction_shares": "12210.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "25297.1838"
    },
    {
      "id": 147741,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-02-12",
      "transaction_shares": "12210.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "25297.1838"
    },
    {
      "id": 176742,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-02-12",
      "transaction_shares": "12210.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "25297.1838"
    },
    {
      "id": 208230,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-02-12",
      "transaction_shares": "12210.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "25297.1838"
    },
    {
      "id": 242236,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-02-12",
      "transaction_shares": "12210.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "25297.1838"
    },
    {
      "id": 280024,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-02-12",
      "transaction_shares": "12210.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "25297.1838"
    },
    {
      "id": 323186,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-02-12",
      "transaction_shares": "12210.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "25297.1838"
    },
    {
      "id": 369865,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-02-12",
      "transaction_shares": "12210.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "25297.1838"
    },
    {
      "id": 1588,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-08",
      "transaction_shares": "7056.0000",
      "transaction_price": "36.8633",
      "transaction_type": "M",
      "shares_after_transaction": "34036.0000"
    },
    {
      "id": 8473,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-08",
      "transaction_shares": "7056.0000",
      "transaction_price": "36.8633",
      "transaction_type": "M",
      "shares_after_transaction": "34036.0000"
    },
    {
      "id": 19850,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-08",
      "transaction_shares": "7056.0000",
      "transaction_price": "36.8633",
      "transaction_type": "M",
      "shares_after_transaction": "34036.0000"
    },
    {
      "id": 34279,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-08",
      "transaction_shares": "7056.0000",
      "transaction_price": "36.8633",
      "transaction_type": "M",
      "shares_after_transaction": "34036.0000"
    },
    {
      "id": 52445,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-08",
      "transaction_shares": "7056.0000",
      "transaction_price": "36.8633",
      "transaction_type": "M",
      "shares_after_transaction": "34036.0000"
    },
    {
      "id": 73103,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-08",
      "transaction_shares": "7056.0000",
      "transaction_price": "36.8633",
      "transaction_type": "M",
      "shares_after_transaction": "34036.0000"
    },
    {
      "id": 95885,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-08",
      "transaction_shares": "7056.0000",
      "transaction_price": "36.8633",
      "transaction_type": "M",
      "shares_after_transaction": "34036.0000"
    },
    {
      "id": 120796,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-08",
      "transaction_shares": "7056.0000",
      "transaction_price": "36.8633",
      "transaction_type": "M",
      "shares_after_transaction": "34036.0000"
    },
    {
      "id": 147707,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-08",
      "transaction_shares": "7056.0000",
      "transaction_price": "36.8633",
      "transaction_type": "M",
      "shares_after_transaction": "34036.0000"
    },
    {
      "id": 176708,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-08",
      "transaction_shares": "7056.0000",
      "transaction_price": "36.8633",
      "transaction_type": "M",
      "shares_after_transaction": "34036.0000"
    },
    {
      "id": 208194,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-08",
      "transaction_shares": "7056.0000",
      "transaction_price": "36.8633",
      "transaction_type": "M",
      "shares_after_transaction": "34036.0000"
    },
    {
      "id": 242199,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-08",
      "transaction_shares": "7056.0000",
      "transaction_price": "36.8633",
      "transaction_type": "M",
      "shares_after_transaction": "34036.0000"
    },
    {
      "id": 279981,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-08",
      "transaction_shares": "7056.0000",
      "transaction_price": "36.8633",
      "transaction_type": "M",
      "shares_after_transaction": "34036.0000"
    },
    {
      "id": 323142,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-08",
      "transaction_shares": "7056.0000",
      "transaction_price": "36.8633",
      "transaction_type": "M",
      "shares_after_transaction": "34036.0000"
    },
    {
      "id": 369819,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-08",
      "transaction_shares": "7056.0000",
      "transaction_price": "36.8633",
      "transaction_type": "M",
      "shares_after_transaction": "34036.0000"
    },
    {
      "id": 1586,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-05",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 8470,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-05",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 19846,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-05",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 34273,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-05",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 52439,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-05",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 73096,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-05",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 95878,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-05",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 120788,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-05",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 147698,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-05",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 176699,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-05",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 208185,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-05",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 242190,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-05",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 279971,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-05",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 323132,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-05",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 369809,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-05",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 1595,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-01",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26503.0000"
    },
    {
      "id": 8485,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-01",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26503.0000"
    },
    {
      "id": 19865,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-01",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26503.0000"
    },
    {
      "id": 34317,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-01",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26503.0000"
    },
    {
      "id": 52486,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-01",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26503.0000"
    },
    {
      "id": 73148,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-01",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26503.0000"
    },
    {
      "id": 95932,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-01",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26503.0000"
    },
    {
      "id": 120844,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-01",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26503.0000"
    },
    {
      "id": 147755,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-01",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26503.0000"
    },
    {
      "id": 176756,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-01",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26503.0000"
    },
    {
      "id": 208246,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-01",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26503.0000"
    },
    {
      "id": 242252,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-01",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26503.0000"
    },
    {
      "id": 280041,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-01",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26503.0000"
    },
    {
      "id": 323205,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-01",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26503.0000"
    },
    {
      "id": 369884,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-02-01",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26503.0000"
    }
  ]
}